Hemoglobin	B-GP
Is	O
a	O
Co	O
-	O
Factor	O
of	O
Human	B-OG
Trypanosome	B-OG
Lytic	O
Factor	O

Trypanosome	B-OG
lytic	O
factor	O
(	O
TLF	O
)	O
is	O
a	O
high	O
-	O
density	O
lipoprotein	O
(	O
HDL	O
)	O
subclass	O
providing	O
innate	O
protection	O
to	O
humans	B-OG
against	O
infection	B-DS
by	O
the	O
protozoan	B-OG
parasite	I-OG
Trypanosoma	B-OG
brucei	I-OG
brucei	I-OG
.	O
Two	O
primate	B-OG
-	O
specific	O
plasma	O
proteins	O
,	O
haptoglobin	B-GP
-	I-GP
related	I-GP
protein	I-GP
(	O
Hpr	B-GP
)	O
and	O
apolipoprotein	B-GP
L	I-GP
-	I-GP
1	I-GP
(	O
ApoL	B-GP
-	I-GP
1	I-GP
),	O
have	O
been	O
proposed	O
to	O
kill	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
both	O
singularly	O
or	O
when	O
co	O
-	O
assembled	O
into	O
the	O
same	O
HDL	O
.	O

To	O
better	O
understand	O
the	O
mechanism	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
killing	O
by	O
TLF	O
,	O
the	O
protein	O
composition	O
of	O
TLF	O
was	O
investigated	O
using	O
a	O
gentle	O
immunoaffinity	O
purification	O
technique	O
that	O
avoids	O
the	O
loss	O
of	O
weakly	O
associated	O
proteins	O
.	O

HDL	O
particles	O
recovered	O
by	O
immunoaffinity	O
absorption	O
,	O
with	O
either	O
anti	O
-	O
Hpr	B-GP
or	O
anti	O
-	O
ApoL	B-GP
-	I-GP
1	I-GP
,	O
were	O
identical	O
in	O
protein	O
composition	O
and	O
specific	O
activity	O
for	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
killing	O
.	O

Here	O
,	O
we	O
show	O
that	O
TLF	O
-	O
bound	O
Hpr	B-GP
strongly	O
binds	O
Hb	B-GP
and	O
that	O
addition	O
of	O
Hb	B-GP
stimulates	O
TLF	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
by	O
increasing	O
the	O
affinity	O
of	O
TLF	O
for	O
its	O
receptor	O
,	O
and	O
by	O
inducing	O
Fenton	O
chemistry	O
within	O
the	O
trypanosome	B-OG
lysosome	O
.	O
These	O
findings	O
suggest	O
that	O
TLF	O
in	O
uninfected	O
humans	B-OG
may	O
be	O
inactive	O
against	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
prior	O
to	O
initiation	O
of	O
infection	B-DS
.	O

We	O
propose	O
that	O
infection	B-DS
of	O
humans	B-OG
by	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
causes	O
hemolysis	O
that	O
triggers	O
the	O
activation	O
of	O
TLF	O
by	O
the	O
formation	O
of	O
Hpr	B-GP
–	O
Hb	B-GP
complexes	O
,	O
leading	O
to	O
enhanced	O
binding	O
,	O
trypanolytic	O
activity	O
,	O
and	O
clearance	O
of	O
parasites	O
.	O

Author	O
Summary	O

African	O
trypanosomes	B-OG
are	O
parasites	O
that	O
can	O
infect	O
a	O
wide	O
range	O
of	O
mammals	B-OG
,	O
including	O
domestic	O
animals	B-OG
and	O
humans	B-OG
.	O

Several	O
hundred	O
thousand	O
humans	B-OG
are	O
infected	O
with	O
African	B-DS
sleeping	I-DS
sickness	I-DS
,	O
but	O
this	O
number	O
would	O
be	O
much	O
higher	O
if	O
not	O
for	O
a	O
natural	O
defense	O
molecule	O
found	O
in	O
human	B-OG
blood	O
.	O

The	O
trypanosome	B-OG
lytic	O
factor	O
(	O
TLF	O
)	O
is	O
a	O
minor	O
subclass	O
of	O
high	O
-	O
density	O
lipoprotein	O
that	O
contains	O
two	O
proteins	O
found	O
only	O
in	O
primates	B-OG
,	O
apolipoprotein	B-GP
L	I-GP
-	I-GP
1	I-GP
and	O
haptoglobin	B-GP
-	I-GP
related	I-GP
protein	I-GP
(	O
Hpr	B-GP
).	O

In	O
this	O
paper	O
,	O
we	O
show	O
that	O
Hpr	B-GP
contributes	O
to	O
TLF	O
toxicity	O
to	O
trypanosomes	B-OG
because	O
it	O
binds	O
hemoglobin	B-GP
(	O
Hb	B-GP
).	O

We	O
found	O
that	O
when	O
Hb	B-GP
is	O
bound	O
to	O
TLF	O
,	O
it	O
is	O
rapidly	O
taken	O
up	O
by	O
the	O
parasite	O
and	O
activated	O
within	O
the	O
acidic	O
environment	O
of	O
the	O
parasite	O
'	O
s	O
digestive	O
organelle	O
,	O
the	O
lysosome	O
.	O

Within	O
the	O
lysosome	O
,	O
Hb	B-GP
releases	O
iron	O
,	O
inducing	O
a	O
chemical	O
reaction	O
that	O
produces	O
free	O
radicals	O
that	O
damage	O
membranes	O
and	O
contributes	O
to	O
trypanosome	B-OG
killing	O
.	O

Usually	O
,	O
free	O
Hb	B-GP
is	O
rapidly	O
cleared	O
from	O
the	O
circulation	O
of	O
mammals	B-OG
because	O
of	O
the	O
organ	O
damage	O
free	O
Hb	B-GP
can	O
cause	O
.	O

Trypanosome	B-DS
infection	I-DS
results	O
in	O
breakage	O
of	O
red	O
blood	O
cells	O
and	O
the	O
release	O
of	O
large	O
amounts	O
of	O
Hb	B-GP
.	O

We	O
postulate	O
that	O
trypanosome	B-DS
infection	I-DS
causes	O
increased	O
vascular	O
levels	O
of	O
Hb	B-GP
,	O
resulting	O
in	O
the	O
formation	O
of	O
TLF	O
–	O
Hb	B-GP
complexes	O
that	O
may	O
be	O
important	O
in	O
“	O
arming	O
”	O
the	O
human	B-OG
innate	O
immune	O
system	O
to	O
clear	O
the	O
circulation	O
of	O
certain	O
African	O
trypanosomes	B-OG
.	O

Introduction	O

African	O
trypanosomes	B-OG
are	O
blood	O
parasites	O
of	O
mammals	B-OG
in	O
sub	O
-	O
Saharan	O
Africa	O
that	O
cause	O
chronic	B-DS
wasting	I-DS
diseases	I-DS
in	O
both	O
humans	B-OG
and	O
domestic	O
animals	B-OG
[	O
1	O
].	O

The	O
three	O
subspecies	O
of	O
Trypanosoma	B-OG
brucei	I-OG
are	O
defined	O
by	O
their	O
host	O
range	O
,	O
geographical	O
distribution	O
,	O
and	O
course	O
of	O
disease	O
[	O
1	O
–	O
3	O
].	O
Trypanosoma	B-OG
brucei	I-OG
rhodesiense	I-OG
and	O
Trypanosoma	B-OG
brucei	I-OG
gambiense	I-OG
infect	O
humans	B-OG
and	O
cause	O
African	B-DS
sleeping	I-DS
sickness	I-DS
,	O
while	O
Trypanosoma	B-OG
brucei	I-OG
brucei	I-OG
infects	O
non	O
-	O
primate	B-OG
mammals	B-OG
and	O
causes	O
nagana	B-DS
in	O
cattle	B-OG
.	O

All	O
African	O
trypanosomes	B-OG
are	O
able	O
to	O
evade	O
the	O
host	O
adaptive	O
immune	O
system	O
through	O
a	O
process	O
called	O
antigenic	O
variation	O
,	O
which	O
is	O
a	O
consequence	O
of	O
periodic	O
changes	O
in	O
the	O
variant	O
surface	O
glycoprotein	B-GP
that	O
covers	O
the	O
entire	O
parasite	O
[	O
4	O
].	O

T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
does	O
not	O
cause	O
human	B-OG
disease	O
because	O
of	O
its	O
susceptibility	O
to	O
an	O
innate	O
immune	O
activity	O
in	O
human	B-OG
serum	O
.	O

This	O
protection	O
is	O
conferred	O
by	O
trypanosome	B-OG
lytic	O
factor	O
(	O
TLF	O
),	O
a	O
minor	O
subclass	O
of	O
human	B-OG
high	O
-	O
density	O
lipoprotein	O
(	O
HDL	O
)	O
[	O
5	O
–	O
7	O
].	O

TLF	O
contains	O
apolipoprotein	B-GP
A	I-GP
-	I-GP
I	I-GP
(	O
ApoA	B-GP
-	I-GP
1	I-GP
),	O
a	O
protein	O
found	O
in	O
all	O
subclasses	O
of	O
HDL	O
,	O
and	O
two	O
proteins	O
,	O
haptoglobin	B-GP
-	I-GP
related	I-GP
protein	I-GP
(	O
Hpr	B-GP
)	O
and	O
apolipoprotein	B-GP
L	I-GP
-	I-GP
1	I-GP
(	O
ApoL	B-GP
-	I-GP
1	I-GP
)	O
that	O
are	O
unique	O
to	O
primates	B-OG
[	O
8	O
–	O
19	O
].	O

Both	O
Hpr	B-GP
and	O
ApoL	B-GP
-	I-GP
1	I-GP
have	O
been	O
reported	O
to	O
be	O
toxic	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
[	O
8	O
,	O
14	O
].	O

The	O
cellular	O
pathway	O
for	O
TLF	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
initiates	O
with	O
binding	O
of	O
TLF	O
to	O
high	O
-	O
affinity	O
receptors	O
located	O
in	O
the	O
flagellar	O
pocket	O
of	O
the	O
parasite	O
[	O
20	O
,	O
21	O
].	O

Bound	O
TLF	O
is	O
endocytosed	O
via	O
coated	O
vesicles	O
and	O
traffics	O
to	O
the	O
parasite	O
lysosome	O
.	O

Within	O
the	O
acidified	O
lysosome	O
,	O
TLF	O
is	O
activated	O
and	O
causes	O
parasite	O
lysis	O
[	O
22	O
–	O
24	O
].	O

ApoL	B-GP
-	I-GP
1	I-GP
and	O
Hpr	B-GP
have	O
been	O
proposed	O
to	O
have	O
different	O
mechanisms	O
of	O
toxicity	O
and	O
may	O
act	O
synergistically	O
.	O

ApoL	B-GP
-	I-GP
1	I-GP
is	O
a	O
colicin	B-GP
-	O
like	O
protein	O
that	O
kills	O
trypanosomes	B-OG
through	O
the	O
formation	O
of	O
ion	O
pores	O
[	O
10	O
,	O
25	O
–	O
29	O
].	O

Hpr	B-GP
is	O
a	O
hemoglobin	B-GP
(	O
Hb	B-GP
)-	O
binding	O
protein	O
that	O
has	O
been	O
proposed	O
to	O
induce	O
an	O
iron	O
-	O
dependent	O
,	O
Fenton	O
-	O
like	O
reaction	O
within	O
the	O
acidic	O
lysosome	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
that	O
leads	O
to	O
the	O
formation	O
of	O
free	O
radicals	O
and	O
peroxidation	O
of	O
the	O
lysosomal	O
membranes	O
[	O
15	O
,	O
24	O
,	O
30	O
].	O

When	O
ApoL	B-GP
-	I-GP
1	I-GP
and	O
Hpr	B-GP
are	O
present	O
in	O
the	O
same	O
HDL	O
particle	O
,	O
the	O
specific	O
activity	O
for	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
killing	O
is	O
enhanced	O
800	O
-	O
fold	O
[	O
14	O
].	O

Hpr	B-GP
is	O
91	O
%	O
identical	O
to	O
haptoglobin	B-GP
(	O
Hp	B-GP
),	O
an	O
abundant	O
(∼	O
0	O
.	O
45	O
–	O
3	O
mg	O
/	O
ml	O
in	O
normal	O
human	B-OG
serum	O
)	O
acute	O
phase	O
serum	O
protein	O
,	O
possessing	O
very	O
high	O
affinity	O
for	O
Hb	B-GP
[	O
31	O
].	O

Complexes	O
of	O
Hp	B-GP
and	O
Hb	B-GP
that	O
form	O
when	O
Hb	B-GP
is	O
released	O
from	O
erythrocytes	O
undergoing	O
intravascular	O
hemolysis	O
are	O
removed	O
from	O
the	O
circulation	O
by	O
the	O
CD163	B-GP
scavenger	B-GP
receptor	I-GP
[	O
32	O
].	O

In	O
contrast	O
to	O
Hp	B-GP
–	O
Hb	B-GP
,	O
the	O
Hpr	B-GP
–	O
Hb	B-GP
complex	O
does	O
not	O
bind	O
CD163	B-GP
[	O
31	O
,	O
33	O
],	O
and	O
the	O
Hpr	B-GP
serum	O
concentration	O
appears	O
to	O
be	O
unaffected	O
by	O
hemolysis	O
[	O
32	O
,	O
33	O
].	O

A	O
role	O
for	O
Hb	B-GP
in	O
trypanolysis	O
has	O
previously	O
been	O
speculated	O
but	O
this	O
view	O
was	O
subsequently	O
debated	O
[	O
12	O
,	O
15	O
,	O
30	O
].	O

In	O
light	O
of	O
this	O
,	O
the	O
biological	O
significance	O
of	O
the	O
recently	O
reported	O
high	O
-	O
affinity	O
binding	O
of	O
recombinant	O
Hpr	B-GP
to	O
Hb	B-GP
remains	O
enigmatic	O
.	O

In	O
the	O
present	O
study	O
we	O
have	O
re	O
-	O
investigated	O
a	O
potential	O
function	O
of	O
Hb	B-GP
in	O
relation	O
to	O
TLF	O
and	O
trypanolysis	O
.	O

Hb	B-GP
was	O
absent	O
from	O
TLF	O
purified	O
from	O
freshly	O
collected	O
human	B-OG
plasma	O
using	O
a	O
gentle	O
immunoabsorption	O
protocol	O
.	O

Nevertheless	O
,	O
Hb	B-GP
bound	O
to	O
purified	O
native	O
Hpr	B-GP
,	O
as	O
well	O
as	O
TLF	O
,	O
with	O
high	O
-	O
affinity	O
and	O
stimulated	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
killing	O
in	O
vitro	O
.	O

The	O
association	O
of	O
Hb	B-GP
with	O
Hpr	B-GP
significantly	O
increased	O
TLF	O
binding	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
.	O

Furthermore	O
,	O
both	O
an	O
iron	O
chelator	O
and	O
a	O
free	O
radical	O
scavenger	O
inhibited	O
cell	O
lysis	O
,	O
suggesting	O
a	O
direct	O
role	O
for	O
Hb	B-GP
-	O
derived	O
iron	O
in	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
killing	O
by	O
TLF	O
.	O

A	O
combination	O
of	O
the	O
ion	O
pore	O
–	O
forming	O
activity	O
of	O
ApoL	B-GP
-	I-GP
1	I-GP
and	O
free	O
radical	O
production	O
of	O
Hpr	B-GP
–	O
Hb	B-GP
may	O
account	O
for	O
the	O
synergy	O
observed	O
in	O
HDLs	O
containing	O
these	O
proteins	O
.	O

Results	O

Analysis	O
of	O
TLF	O
Protein	O
Components	O

In	O
order	O
to	O
define	O
the	O
protein	O
composition	O
of	O
native	O
TLF	O
,	O
freshly	O
prepared	O
human	B-OG
plasma	O
was	O
fractionated	O
by	O
“	O
one	O
-	O
step	O
”	O
immunoaffinity	O
chromatography	O
with	O
antibodies	O
against	O
Hpr	B-GP
or	O
ApoL	B-GP
-	I-GP
1	I-GP
.	O

Unlike	O
the	O
“	O
two	O
-	O
step	O
”	O
method	O
that	O
initially	O
uses	O
high	O
-	O
salt	O
density	O
ultracentrifugation	O
followed	O
by	O
immunoaffinity	O
chromatography	O
to	O
purify	O
TLF	O
,	O
the	O
one	O
-	O
step	O
method	O
eliminates	O
the	O
possible	O
loss	O
of	O
apolipoproteins	B-GP
during	O
the	O
high	O
-	O
salt	O
centrifugation	O
step	O
[	O
34	O
].	O

These	O
methods	O
allowed	O
us	O
to	O
make	O
two	O
comparisons	O
:	O
First	O
,	O
a	O
comparison	O
of	O
proteins	O
purified	O
by	O
the	O
one	O
-	O
step	O
purification	O
protocol	O
with	O
proteins	O
purified	O
by	O
the	O
two	O
-	O
step	O
purification	O
protocol	O
.	O

Second	O
,	O
it	O
allowed	O
us	O
to	O
compare	O
the	O
composition	O
of	O
TLF	O
purified	O
by	O
the	O
one	O
-	O
step	O
purification	O
method	O
using	O
antibodies	O
to	O
ApoL	B-GP
-	I-GP
1	I-GP
or	O
Hpr	B-GP
.	O

Previous	O
analysis	O
of	O
the	O
protein	O
composition	O
of	O
TLF	O
,	O
purified	O
by	O
the	O
two	O
-	O
step	O
procedure	O
,	O
demonstrated	O
the	O
presence	O
of	O
ApoA	B-GP
-	I-GP
1	I-GP
,	O
ApoL	B-GP
-	I-GP
1	I-GP
,	O
Hpr	B-GP
dimer	O
,	O
and	O
Hpr	B-GP
tetramer	O
(	O
Figure	O
1A	O
)	O
[	O
14	O
].	O

Comparison	O
of	O
proteins	O
purified	O
by	O
the	O
two	O
procedures	O
by	O
SDS	O
-	O
PAGE	O
and	O
western	O
blot	O
analysis	O
showed	O
that	O
the	O
protein	O
compositions	O
were	O
similar	O
in	O
both	O
cases	O
(	O
Figure	O
1	O
).	O

This	O
shows	O
that	O
high	O
-	O
salt	O
density	O
ultracentrifugation	O
used	O
in	O
the	O
two	O
-	O
step	O
protocol	O
does	O
not	O
dramatically	O
change	O
the	O
protein	O
composition	O
of	O
the	O
TLF	O
particle	O
.	O

Two	O
differences	O
were	O
noticed	O
.	O

First	O
,	O
the	O
ratio	O
of	O
Hpr	B-GP
dimer	O
to	O
tetramer	O
was	O
higher	O
in	O
samples	O
purified	O
using	O
the	O
single	O
-	O
step	O
immunoabsorption	O
method	O
.	O

Second	O
,	O
there	O
was	O
a	O
reduction	O
in	O
sub	O
-	O
stoichiometric	O
proteins	O
in	O
preparations	O
of	O
TLF	O
purified	O
by	O
the	O
two	O
-	O
step	O
purification	O
method	O
.	O

Specifically	O
,	O
a	O
significant	O
amount	O
of	O
Hp	B-GP
,	O
albumin	B-GP
,	O
and	O
transferrin	B-GP
was	O
detected	O
by	O
SDS	O
-	O
PAGE	O
,	O
western	O
blotting	O
,	O
and	O
liquid	O
chromatography	O
/	O
mass	O
spectrometry	O
/	O
mass	O
spectrometry	O
(	O
LC	O
-	O
MS	O
/	O
MS	O
)	O
in	O
the	O
one	O
-	O
step	O
purified	O
material	O
(	O
Figure	O
1A	O
–	O
1C	O
,	O
Table	O
1	O
).	O

In	O
addition	O
to	O
these	O
serum	O
proteins	O
,	O
other	O
human	B-OG
serum	O
proteins	O
,	O
including	O
angiotensinogen	B-GP
and	O
intellectin	B-GP
,	O
were	O
detected	O
at	O
low	O
abundance	O
by	O
LC	O
-	O
MS	O
/	O
MS	O
analysis	O
(	O
unpublished	O
data	O
).	O

Notably	O
,	O
no	O
Hb	B-GP
was	O
detected	O
in	O
any	O
of	O
the	O
TLF	O
preparations	O
.	O

Analysis	O
of	O
Differentially	O
Purified	O
Human	B-OG
Serum	O
HDLs	O

(	O
A	O
)	O
TLF	O
analyzed	O
by	O
non	O
-	O
reducing	O
10	O
%	O
SDS	O
-	O
PAGE	O
and	O
Coomassie	O
brilliant	O
blue	O
staining	O
after	O
purification	O
by	O
a	O
two	O
-	O
step	O
purification	O
process	O
that	O
includes	O
high	O
-	O
salt	O
density	O
centrifugation	O
and	O
antibody	O
affinity	O
chromatography	O
with	O
anti	O
-	O
Hpr	B-GP
.	O

The	O
presence	O
of	O
albumin	B-GP
(	O
Alb	B-GP
)	O
and	O
immunoglobulin	B-GP
(	O
Ig	B-GP
)	O
are	O
indicated	O
.	O

(	O
B	O
)	O
HDL	O
purified	O
from	O
serum	O
using	O
a	O
single	O
-	O
step	O
affinity	O
purification	O
method	O
with	O
antibodies	O
to	O
ApoL	B-GP
-	I-GP
1	I-GP
,	O
Hpr	B-GP
,	O
or	O
ApoA	B-GP
-	I-GP
1	I-GP
and	O
analyzed	O
by	O
non	O
-	O
reducing	O
10	O
%	O
SDS	O
-	O
PAGE	O
and	O
stained	O
with	O
Coomassie	O
brilliant	O
blue	O
.	O

Tf	B-GP
,	O
transferrin	B-GP
.	O

(	O
C	O
)	O
The	O
same	O
gel	O
as	O
in	O
(	O
B	O
)	O
transferred	O
to	O
nitrocellulose	O
and	O
probed	O
with	O
antibodies	O
to	O
transferrin	B-GP
(	O
Tf	B-GP
),	O
Hpr	B-GP
,	O
ApoL	B-GP
-	I-GP
1	I-GP
,	O
and	O
ApoA	B-GP
-	I-GP
1	I-GP
.	O

Mass	O
Spectroscopy	O
Analysis	O
of	O
TLF	O

In	O
order	O
to	O
determine	O
whether	O
the	O
protein	O
composition	O
of	O
HDLs	O
containing	O
Hpr	B-GP
or	O
ApoL	B-GP
-	I-GP
1	I-GP
differed	O
significantly	O
,	O
samples	O
were	O
purified	O
from	O
human	B-OG
plasma	O
by	O
the	O
one	O
-	O
step	O
immunoaffinity	O
method	O
using	O
antibodies	O
to	O
Hpr	B-GP
,	O
ApoL	B-GP
-	I-GP
1	I-GP
,	O
or	O
ApoA	B-GP
-	I-GP
1	I-GP
.	O

All	O
samples	O
were	O
analyzed	O
by	O
Coomassie	O
staining	O
,	O
western	O
blot	O
,	O
and	O
LC	O
-	O
MS	O
/	O
MS	O
(	O
Figure	O
1	O
;	O
Table	O
1	O
).	O

The	O
protein	O
composition	O
of	O
samples	O
purified	O
by	O
anti	O
-	O
Hpr	B-GP
or	O
anti	O
-	O
ApoL	B-GP
-	I-GP
1	I-GP
absorption	O
was	O
indistinguishable	O
.	O

The	O
similar	O
ratio	O
of	O
Hpr	B-GP
and	O
ApoL	B-GP
-	I-GP
1	I-GP
,	O
in	O
the	O
samples	O
purified	O
with	O
anti	O
-	O
Hpr	B-GP
and	O
anti	O
-	O
ApoL	B-GP
-	I-GP
1	I-GP
,	O
indicates	O
that	O
most	O
serum	O
Hpr	B-GP
and	O
ApoL	B-GP
-	I-GP
1	I-GP
are	O
assembled	O
into	O
the	O
same	O
HDL	O
.	O

The	O
major	O
proteins	O
present	O
in	O
samples	O
purified	O
by	O
anti	O
-	O
ApoA	B-GP
-	I-GP
1	I-GP
immunoaffinity	O
chromatography	O
were	O
ApoA	B-GP
-	I-GP
1	I-GP
,	O
Hp	B-GP
,	O
and	O
transferrin	B-GP
.	O

Only	O
trace	O
amounts	O
of	O
ApoL	B-GP
-	I-GP
1	I-GP
and	O
Hpr	B-GP
were	O
detected	O
in	O
these	O
samples	O
,	O
consistent	O
with	O
TLF	O
being	O
a	O
minor	O
subclass	O
of	O
human	B-OG
HDL	O
[	O
6	O
].	O

These	O
findings	O
rule	O
out	O
the	O
possibility	O
that	O
a	O
significant	O
amount	O
of	O
human	B-OG
plasma	O
Hpr	B-GP
or	O
ApoL	B-GP
-	I-GP
1	I-GP
is	O
free	O
in	O
the	O
circulation	O
and	O
suggests	O
a	O
pathway	O
for	O
co	O
-	O
assembly	O
of	O
these	O
two	O
apolipoproteins	B-GP
into	O
the	O
same	O
HDL	O
particle	O
.	O

Analysis	O
of	O
Differentially	O
Purified	O
TLF	O
Lytic	O
Activity	O

The	O
specific	O
activity	O
of	O
TLF	O
purified	O
by	O
the	O
one	O
-	O
step	O
method	O
using	O
antibodies	O
to	O
either	O
Hpr	B-GP
or	O
ApoL	B-GP
-	I-GP
1	I-GP
was	O
similar	O
.	O

In	O
our	O
standard	O
lysis	O
assay	O
,	O
0	O
.	O
5	O
μg	O
resulted	O
in	O
40	O
%	O
lysis	O
in	O
2	O
h	O
at	O
37	O
°	O
C	O
(	O
Figure	O
2A	O
).	O

Human	B-OG
plasma	O
samples	O
purified	O
with	O
anti	O
-	O
ApoA	B-GP
-	I-GP
1	I-GP
were	O
also	O
trypanolytic	O
,	O
but	O
the	O
specific	O
activity	O
for	O
killing	O
was	O
reduced	O
over	O
10	O
-	O
fold	O
(	O
Figure	O
2A	O
).	O

The	O
low	O
specific	O
activity	O
of	O
the	O
ApoA	B-GP
-	I-GP
1	I-GP
-	O
purified	O
samples	O
was	O
due	O
to	O
the	O
relatively	O
low	O
ratio	O
of	O
TLF	O
to	O
non	O
-	O
lytic	O
HDL	O
in	O
this	O
preparation	O
.	O

This	O
is	O
consistent	O
with	O
previous	O
estimates	O
of	O
TLF	O
abundance	O
,	O
suggesting	O
it	O
represents	O
less	O
than	O
0	O
.	O
1	O
%	O
of	O
total	O
human	B-OG
serum	O
HDL	O
[	O
6	O
,	O
14	O
].	O

Lysis	O
and	O
Morphology	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
Killed	O
with	O
Purified	O
HDL	O

(	O
A	O
)	O
Human	B-OG
HDLs	O
were	O
purified	O
by	O
a	O
single	O
-	O
step	O
immunoaffinity	O
method	O
with	O
either	O
anti	O
-	O
Hpr	B-GP
,	O
anti	O
-	O
ApoL	B-GP
-	I-GP
1	I-GP
,	O
or	O
anti	O
-	O
ApoA	B-GP
-	I-GP
1	I-GP
.	O

The	O
specific	O
activity	O
for	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
killing	O
was	O
similar	O
for	O
TLF	O
purified	O
with	O
the	O
single	O
-	O
step	O
protocol	O
with	O
either	O
anti	O
-	O
Hpr	B-GP
(	O
closed	O
circles	O
)	O
or	O
anti	O
-	O
ApoL	B-GP
-	I-GP
1	I-GP
(	O
open	O
circles	O
)	O
(∼	O
0	O
.	O
5	O
μg	O
/	O
ml	O
killed	O
40	O
%	O
of	O
the	O
trypanosomes	B-OG
in	O
our	O
standard	O
assay	O
).	O

The	O
specific	O
activity	O
of	O
samples	O
purified	O
with	O
single	O
-	O
step	O
immunoabsorption	O
with	O
anti	O
-	O
ApoA	B-GP
-	I-GP
1	I-GP
(	O
closed	O
squares	O
)	O
was	O
over	O
10	O
-	O
fold	O
reduced	O
in	O
specific	O
activity	O
for	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
killing	O
.	O

(	O
B	O
)	O
TLF	O
purified	O
by	O
a	O
two	O
-	O
step	O
method	O
using	O
both	O
high	O
-	O
salt	O
density	O
gradient	O
ultracentrifugation	O
and	O
immunoaffinity	O
absorption	O
.	O

TLF	O
first	O
subjected	O
to	O
high	O
-	O
salt	O
gradient	O
ultracentrifugation	O
was	O
10	O
-	O
fold	O
more	O
toxic	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
than	O
TLF	O
purified	O
by	O
the	O
single	O
-	O
step	O
immunoabsorption	O
directly	O
from	O
serum	O
.	O

Similar	O
specific	O
activities	O
were	O
obtained	O
when	O
the	O
second	O
immunoaffinity	O
step	O
was	O
conducted	O
with	O
either	O
anti	O
-	O
Hpr	B-GP
(	O
closed	O
circles	O
)	O
or	O
anti	O
-	O
ApoL	B-GP
-	I-GP
1	I-GP
(	O
open	O
circles	O
).	O

The	O
specific	O
activity	O
of	O
HDLs	O
purified	O
with	O
anti	O
-	O
ApoA	B-GP
-	I-GP
1	I-GP
(	O
closed	O
squares	O
)	O
was	O
over	O
100	O
-	O
fold	O
lower	O
.	O

(	O
C	O
–	O
F	O
)	O
Cell	O
morphology	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
treated	O
with	O
TLF	O
purified	O
by	O
single	O
-	O
step	O
immunoaffinity	O
with	O
anti	O
-	O
ApoL	B-GP
-	I-GP
1	I-GP
or	O
anti	O
-	O
Hpr	B-GP
.	O

Following	O
incubation	O
at	O
37	O
°	O
C	O
for	O
2	O
h	O
,	O
cells	O
were	O
either	O
smeared	O
on	O
microscope	O
slides	O
and	O
methanol	O
fixed	O
(	O
C	O
and	O
E	O
)	O
or	O
directly	O
viewed	O
following	O
imbedding	O
in	O
1	O
%	O
agarose	O
(	O
D	O
and	O
F	O
).	O

Incubation	O
with	O
TLF	O
purified	O
either	O
by	O
anti	O
-	O
Hpr	B-GP
(	O
C	O
and	O
D	O
)	O
or	O
anti	O
-	O
ApoL	B-GP
-	I-GP
1	I-GP
(	O
E	O
and	O
F	O
)	O
immunoabsorption	O
showed	O
similar	O
morphologies	O
.	O

Prior	O
to	O
lysis	O
all	O
cells	O
progressed	O
through	O
a	O
series	O
of	O
morphological	O
changes	O
that	O
included	O
transition	O
to	O
a	O
kite	O
-	O
shaped	O
form	O
and	O
continued	O
swelling	O
until	O
lysis	O
.	O

The	O
position	O
of	O
the	O
kinetoplast	O
(	O
k	O
)	O
and	O
nucleus	O
(	O
n	O
)	O
was	O
determined	O
by	O
DAPI	O
staining	O
in	O
the	O
fixed	O
preparations	O
(	O
C	O
and	O
E	O
).	O

The	O
nucleus	O
(	O
n	O
)	O
was	O
clearly	O
visible	O
in	O
the	O
unfixed	O
cells	O
(	O
D	O
and	O
F	O
).	O

doi	O
:	O
110	O
.	O
1371	O
/	O
journal	O
.	O
ppat	O
.	O
0030129	O
.	O
g002	O

When	O
plasma	O
samples	O
were	O
purified	O
by	O
the	O
two	O
-	O
step	O
protocol	O
that	O
included	O
high	O
-	O
salt	O
density	O
ultracentrifugation	O
followed	O
by	O
either	O
anti	O
-	O
ApoL	B-GP
-	I-GP
1	I-GP
or	O
anti	O
-	O
Hpr	B-GP
immunoaffinity	O
purification	O
,	O
the	O
specific	O
activity	O
for	O
trypanosome	B-OG
killing	O
was	O
approximately	O
10	O
-	O
fold	O
higher	O
than	O
samples	O
purified	O
by	O
the	O
one	O
-	O
step	O
methods	O
(	O
0	O
.	O
025	O
μg	O
and	O
0	O
.	O
04	O
μg	O
giving	O
∼	O
50	O
%	O
lysis	O
,	O
respectively	O
)	O
(	O
Figure	O
2B	O
).	O

The	O
increased	O
lytic	O
activity	O
of	O
the	O
samples	O
purified	O
by	O
the	O
two	O
-	O
step	O
procedure	O
may	O
be	O
due	O
to	O
the	O
increased	O
purity	O
of	O
these	O
samples	O
.	O

This	O
is	O
because	O
gradient	O
centrifugation	O
employed	O
in	O
the	O
two	O
-	O
step	O
purification	O
process	O
reduces	O
the	O
amount	O
of	O
contaminating	O
,	O
high	O
-	O
abundance	O
serum	O
proteins	O
,	O
such	O
as	O
albumin	B-GP
and	O
transferrin	B-GP
(	O
Figure	O
1A	O
).	O

In	O
addition	O
,	O
Hp	B-GP
,	O
a	O
potent	O
inhibitor	O
of	O
TLF	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
[	O
9	O
],	O
is	O
weakly	O
associated	O
with	O
all	O
human	B-OG
HDL	O
and	O
is	O
effectively	O
removed	O
by	O
high	O
-	O
salt	O
density	O
ultracentrifugation	O
(	O
Figure	O
1A	O
).	O

The	O
mechanism	O
of	O
Hp	B-GP
inhibition	O
of	O
human	B-OG
serum	O
lysis	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
is	O
not	O
known	O
;	O
based	O
on	O
results	O
presented	O
later	O
,	O
inhibition	O
may	O
be	O
a	O
direct	O
consequence	O
of	O
Hp	B-GP
binding	O
to	O
free	O
Hb	B-GP
in	O
serum	O
.	O

Two	O
different	O
morphological	O
phenotypes	O
have	O
been	O
reported	O
for	O
human	B-OG
HDL	O
killing	O
.	O

One	O
is	O
defined	O
by	O
lysosomal	O
membrane	O
breakdown	O
,	O
cell	O
swelling	O
,	O
and	O
trypanosome	B-OG
death	O
[	O
13	O
,	O
24	O
,	O
30	O
,	O
35	O
,	O
36	O
].	O

The	O
other	O
,	O
recently	O
reported	O
by	O
Pays	O
and	O
co	O
-	O
workers	O
,	O
involves	O
extensive	O
lysosome	O
swelling	O
,	O
creating	O
a	O
large	O
cytosolic	O
vacuole	O
that	O
is	O
proposed	O
to	O
exert	O
enough	O
pressure	O
on	O
the	O
plasma	O
membrane	O
that	O
the	O
cell	O
ruptures	O
[	O
8	O
,	O
10	O
,	O
25	O
].	O

Plasma	O
samples	O
purified	O
by	O
either	O
anti	O
-	O
Hpr	B-GP
or	O
anti	O
-	O
ApoL	B-GP
-	I-GP
1	I-GP
immunoaffinity	O
produced	O
identical	O
morphological	O
changes	O
in	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
preceding	O
lysis	O
(	O
Figure	O
2C	O
–	O
2F	O
).	O

After	O
a	O
lag	O
phase	O
of	O
approximately	O
20	O
min	O
,	O
the	O
overall	O
morphology	O
of	O
the	O
cells	O
changed	O
.	O

Swelling	O
was	O
accompanied	O
by	O
an	O
overall	O
change	O
in	O
the	O
shape	O
of	O
the	O
cells	O
,	O
first	O
resulting	O
in	O
a	O
kite	O
-	O
like	O
appearance	O
followed	O
by	O
continued	O
swelling	O
and	O
rounding	O
of	O
the	O
cells	O
until	O
the	O
cells	O
ruptured	O
.	O

The	O
formation	O
of	O
a	O
large	O
cytoplasmic	O
vacuole	O
was	O
not	O
observed	O
.	O

In	O
live	O
cell	O
imaging	O
,	O
the	O
nucleus	O
,	O
nucleolus	O
,	O
flagella	O
,	O
and	O
other	O
organelles	O
are	O
visible	O
(	O
Figure	O
2D	O
and	O
2F	O
).	O

The	O
morphology	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
treated	O
with	O
intact	O
human	B-OG
plasma	O
produces	O
the	O
same	O
morphological	O
changes	O
,	O
leading	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
lysis	O
,	O
like	O
those	O
seen	O
with	O
purified	O
TLF	O
(	O
Figure	O
8C	O
).	O

The	O
reason	O
for	O
the	O
discrepancies	O
between	O
the	O
morphological	O
changes	O
observed	O
by	O
the	O
Pays	O
lab	O
and	O
those	O
observed	O
by	O
us	O
and	O
others	O
following	O
treatment	O
with	O
either	O
purified	O
TLF	O
or	O
intact	O
human	B-OG
serum	O
/	O
plasma	O
remains	O
unresolved	O
.	O

TLF	O
Binding	O
to	O
Hb	B-GP

Previous	O
studies	O
suggested	O
Hpr	B-GP
,	O
despite	O
being	O
highly	O
homologous	O
to	O
Hp	B-GP
,	O
did	O
not	O
bind	O
Hb	B-GP
[	O
12	O
,	O
30	O
].	O

It	O
is	O
likely	O
that	O
Hpr	B-GP
–	O
Hb	B-GP
complexes	O
were	O
not	O
detected	O
in	O
these	O
studies	O
because	O
of	O
the	O
presence	O
of	O
mild	O
,	O
non	O
-	O
ionic	O
detergents	O
in	O
the	O
immunoprecipitation	O
assays	O
.	O

More	O
recently	O
,	O
it	O
has	O
been	O
shown	O
that	O
native	O
and	O
recombinant	O
Hp	B-GP
and	O
recombinant	O
Hpr	B-GP
bind	O
Hb	B-GP
with	O
high	O
affinity	O
and	O
that	O
Hb	B-GP
-	O
coupled	O
Sepharose	O
can	O
precipitate	O
Hpr	B-GP
-	O
containing	O
HDLs	O
from	O
plasma	O
[	O
31	O
].	O

Although	O
our	O
analysis	O
of	O
TLF	O
revealed	O
the	O
presence	O
of	O
Hpr	B-GP
,	O
no	O
Hb	B-GP
was	O
detected	O
in	O
any	O
of	O
the	O
purified	O
HDL	O
preparations	O
.	O

In	O
order	O
to	O
determine	O
whether	O
native	O
TLF	O
and	O
purified	O
native	O
Hpr	B-GP
could	O
bind	O
Hb	B-GP
,	O
surface	O
plasmon	O
resonance	O
(	O
SPR	O
)	O
analysis	O
was	O
performed	O
with	O
purified	O
preparations	O
of	O
native	O
TLF	O
,	O
Hpr	B-GP
,	O
and	O
Hb	B-GP
.	O

TLF	O
and	O
Hpr	B-GP
both	O
bound	O
immobilized	O
Hb	B-GP
with	O
high	O
affinity	O
(	O
the	O
Kd	O
for	O
the	O
Hpr	B-GP
–	O
Hb	B-GP
interaction	O
was	O
2	O
–	O
5	O
nM	O
as	O
estimated	O
by	O
SPR	O
)	O
(	O
Figure	O
3A	O
).	O

The	O
horizontal	O
progress	O
of	O
the	O
curves	O
representing	O
the	O
dissociation	O
phase	O
(	O
after	O
arrows	O
in	O
Figure	O
3A	O
)	O
indicates	O
an	O
almost	O
irreversible	O
binding	O
of	O
Hpr	B-GP
as	O
well	O
as	O
binding	O
of	O
TLF	O
to	O
Hb	B-GP
.	O

Binding	O
of	O
Purified	O
Hpr	B-GP
and	O
TLF	O
to	O
Hb	B-GP

(	O
A	O
)	O
SPR	O
analysis	O
of	O
the	O
binding	O
of	O
purified	O
Hpr	B-GP
(	O
left	O
panel	O
)	O
and	O
TLF	O
purified	O
by	O
the	O
two	O
-	O
step	O
procedure	O
(	O
right	O
panel	O
)	O
to	O
immobilized	O
Hb	B-GP
A0	O
.	O

The	O
concentration	O
of	O
Hpr	B-GP
and	O
TLF	O
is	O
shown	O
to	O
the	O
right	O
of	O
the	O
binding	O
curves	O
.	O

The	O
BIAevaluation	O
4	O
.	O
1	O
software	O
estimated	O
a	O
Kd	O
of	O
2	O
–	O
5	O
nM	O
for	O
the	O
Hpr	B-GP
–	O
Hb	B-GP
complex	O
.	O

Arrows	O
indicate	O
the	O
beginning	O
of	O
the	O
dissociation	O
curves	O
.	O

(	O
B	O
)	O
Silver	O
-	O
stained	O
SDS	O
-	O
polyacrylamide	O
(	O
8	O
%–	O
16	O
%	O
gradient	O
)	O
gel	O
of	O
proteins	O
eluted	O
from	O
Hb	B-GP
-	O
coupled	O
Sepharose	O
(	O
Hb	B-GP
),	O
BSA	O
-	O
coupled	O
Sepharose	O
(	O
BSA	O
),	O
or	O
underivatized	O
Sepharose	O
(	O
blank	O
)	O
after	O
incubation	O
with	O
purified	O
TLF	O
.	O

doi	O
:	O
110	O
.	O
1371	O
/	O
journal	O
.	O
ppat	O
.	O
0030129	O
.	O
g003	O

To	O
ensure	O
that	O
the	O
SPR	O
response	O
observed	O
upon	O
incubation	O
with	O
TLF	O
(	O
Figure	O
3A	O
,	O
right	O
panel	O
)	O
could	O
not	O
be	O
attributed	O
to	O
binding	O
between	O
Hb	B-GP
and	O
Hpr	B-GP
released	O
from	O
the	O
TLF	O
particle	O
,	O
binding	O
of	O
purified	O
TLF	O
to	O
Hb	B-GP
was	O
also	O
studied	O
in	O
a	O
pull	O
-	O
down	O
assay	O
.	O

As	O
revealed	O
in	O
Figure	O
3B	O
,	O
Hb	B-GP
-	O
coupled	O
Sepharose	O
beads	O
specifically	O
bound	O
the	O
entire	O
TLF	O
particle	O
containing	O
Hpr	B-GP
as	O
well	O
as	O
ApoL	B-GP
-	I-GP
1	I-GP
and	O
ApoA	B-GP
-	I-GP
1	I-GP
.	O

Consistent	O
with	O
the	O
recent	O
finding	O
that	O
recombinant	O
Hpr	B-GP
in	O
complex	O
with	O
Hb	B-GP
does	O
not	O
bind	O
the	O
human	B-OG
Hp	B-GP
–	O
Hb	B-GP
receptor	O
CD163	B-GP
,	O
the	O
complex	O
between	O
native	O
Hpr	B-GP
and	O
Hb	B-GP
did	O
not	O
bind	O
to	O
immobilized	O
purified	O
human	B-OG
CD163	B-GP
in	O
the	O
SPR	O
analysis	O
(	O
unpublished	O
data	O
)	O
[	O
31	O
,	O
33	O
].	O

Hb	B-GP
Involvement	O
in	O
TLF	O
Killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG

The	O
observation	O
that	O
Hb	B-GP
binds	O
to	O
purified	O
Hpr	B-GP
and	O
TLF	O
led	O
us	O
to	O
re	O
-	O
investigate	O
the	O
role	O
of	O
Hb	B-GP
in	O
TLF	O
-	O
mediated	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
.	O

Since	O
fetal	O
bovine	O
serum	O
(	O
FBS	O
),	O
a	O
component	O
of	O
our	O
standard	O
trypanosome	B-OG
assay	O
,	O
typically	O
contains	O
small	O
amounts	O
of	O
Hb	B-GP
released	O
by	O
hemolysis	O
during	O
serum	O
preparation	O
,	O
we	O
modified	O
the	O
standard	O
trypanosome	B-OG
lysis	O
assay	O
to	O
eliminate	O
FBS	O
(	O
Figure	O
4A	O
).	O

The	O
killing	O
activity	O
of	O
TLF	O
was	O
drastically	O
reduced	O
when	O
bovine	O
serum	O
albumin	B-GP
(	O
BSA	O
)	O
was	O
substituted	O
for	O
FBS	O
in	O
our	O
in	O
vitro	O
lysis	O
assay	O
.	O

Addition	O
of	O
FBS	O
restored	O
maximal	O
tyrypanosome	O
killing	O
activity	O
in	O
the	O
assay	O
(	O
Figure	O
4B	O
and	O
4C	O
).	O

Effect	O
of	O
FBS	O
on	O
TLF	O
Killing	O
of	O
T	O
.	O
b	O
.	O
brucei	O

(	O
A	O
)	O
FBS	O
(	O
1	O
μl	O
),	O
BSA	O
(	O
1	O
μg	O
),	O
and	O
Hb	B-GP
(	O
1	O
.	O
0	O
μg	O
)	O
were	O
fractionated	O
on	O
15	O
%	O
SDS	O
-	O
PAGE	O
gels	O
and	O
stained	O
with	O
Coomassie	O
.	O

The	O
presence	O
of	O
Hb	B-GP
in	O
FBS	O
was	O
verified	O
by	O
mass	O
spectroscopy	O
of	O
the	O
appropriate	O
sized	O
bands	O
.	O

Both	O
Bos	B-OG
aurus	I-OG
alpha	O
and	O
gamma	O
subunits	O
of	O
Hb	B-GP
were	O
identified	O
,	O
and	O
five	O
of	O
the	O
gamma	B-GP
globin	I-GP
tryptic	O
fragments	O
are	O
shown	O
.	O

(	O
B	O
)	O
FBS	O
is	O
required	O
for	O
maximum	O
in	O
vitro	O
lysis	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
with	O
highly	O
purified	O
TLF	O
.	O

FBS	O
was	O
titrated	O
into	O
a	O
300	O
-	O
μl	O
assay	O
containing	O
1	O
%	O
BSA	O
.	O

Addition	O
of	O
5	O
μl	O
FBS	O
restored	O
lytic	O
levels	O
to	O
those	O
seen	O
in	O
standard	O
lysis	O
assays	O
[	O
8	O
].	O

(	O
C	O
)	O
The	O
effect	O
of	O
FBS	O
addition	O
is	O
concentration	O
dependent	O
.	O

TLF	O
used	O
in	O
these	O
studies	O
was	O
purified	O
by	O
the	O
two	O
-	O
step	O
procedure	O
.	O

To	O
determine	O
whether	O
Hb	B-GP
was	O
the	O
co	O
-	O
factor	O
supplied	O
by	O
the	O
FBS	O
in	O
the	O
in	O
vitro	O
lysis	O
reactions	O
,	O
we	O
titrated	O
Hb	B-GP
into	O
the	O
modified	O
serum	O
-	O
free	O
assay	O
(	O
Figure	O
5A	O
).	O

Hb	B-GP
restores	O
the	O
killing	O
activity	O
of	O
TLF	O
,	O
while	O
the	O
addition	O
of	O
Hb	B-GP
alone	O
is	O
non	O
-	O
toxic	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
even	O
at	O
very	O
high	O
concentrations	O
(	O
Figure	O
5A	O
;	O
Figure	O
S1	O
).	O

Furthermore	O
,	O
if	O
the	O
Hb	B-GP
-	O
binding	O
protein	O
,	O
Hp	B-GP
,	O
is	O
added	O
to	O
the	O
reactions	O
,	O
it	O
inhibits	O
lysis	O
in	O
a	O
concentration	O
-	O
dependent	O
fashion	O
(	O
Figure	O
5B	O
).	O

Together	O
,	O
these	O
results	O
indicate	O
that	O
Hb	B-GP
is	O
a	O
necessary	O
co	O
-	O
factor	O
for	O
maximal	O
TLF	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
and	O
that	O
direct	O
binding	O
of	O
Hb	B-GP
to	O
Hpr	B-GP
may	O
be	O
required	O
.	O

Hb	B-GP
Is	O
the	O
Co	O
-	O
Factor	O
in	O
FBS	O
Necessary	O
for	O
Maximal	O
TLF	O
Killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG

(	O
A	O
)	O
Titration	O
of	O
Hb	B-GP
into	O
in	O
vitro	O
lysis	O
reactions	O
containing	O
highly	O
purified	O
TLF	O
.	O

Samples	O
contained	O
TLF	O
(	O
1	O
.	O
5	O
units	O
)	O
in	O
10	O
%	O
FBS	O
(	O
open	O
circles	O
);	O
TLF	O
(	O
1	O
.	O
5	O
units	O
)	O
in	O
1	O
%	O
BSA	O
and	O
1	O
%	O
glucose	O
(	O
closed	O
circles	O
);	O
Hp	B-GP
in	O
1	O
%	O
BSA	O
and	O
1	O
%	O
glucose	O
without	O
TLF	O
(	O
closed	O
squares	O
);	O
and	O
no	O
TLF	O
(	O
Hb	B-GP
only	O
)	O
(	O
open	O
squares	O
).	O

In	O
the	O
presence	O
of	O
TLF	O
,	O
Hb	B-GP
addition	O
results	O
in	O
a	O
concentration	O
-	O
dependent	O
increase	O
in	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
killing	O
.	O

No	O
increase	O
is	O
seen	O
when	O
Hb	B-GP
is	O
added	O
to	O
FBS	O
-	O
containing	O
reactions	O
because	O
FBS	O
contains	O
approximately	O
0	O
.	O
5	O
μg	O
/	O
μl	O
of	O
Hb	B-GP
.	O

(	O
B	O
)	O
Addition	O
of	O
Hp	B-GP
inhibits	O
Hb	B-GP
-	O
dependent	O
killing	O
by	O
TLF	O
.	O

Hp	B-GP
was	O
titrated	O
into	O
reactions	O
containing	O
TLF	O
(	O
1	O
.	O
5	O
units	O
),	O
1	O
%	O
BSA	O
and	O
1	O
%	O
glucose	O
,	O
and	O
0	O
.	O
1	O
pmol	O
of	O
Hb	B-GP
(	O
closed	O
circles	O
).	O

Addition	O
of	O
Hp	B-GP
and	O
Hb	B-GP
(	O
0	O
.	O
1	O
pmol	O
)	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
in	O
the	O
absence	O
of	O
TLF	O
had	O
no	O
effect	O
on	O
cell	O
viability	O
(	O
open	O
circles	O
).	O

TLF	O
used	O
in	O
these	O
studies	O
was	O
purified	O
by	O
the	O
two	O
-	O
step	O
procedure	O
.	O

TLF	O
–	O
Hb	B-GP
Binding	O
to	O
Trypanosomes	B-OG

Hb	B-GP
could	O
stimulate	O
trypanosome	B-OG
killing	O
either	O
a	O
)	O
by	O
increasing	O
the	O
affinity	O
of	O
TLF	O
for	O
the	O
trypanosome	B-OG
receptor	O
,	O
b	O
)	O
by	O
playing	O
a	O
direct	O
role	O
in	O
the	O
lytic	O
process	O
,	O
or	O
c	O
)	O
by	O
a	O
combination	O
of	O
the	O
above	O
.	O

To	O
test	O
whether	O
Hb	B-GP
was	O
necessary	O
for	O
trypanosome	B-OG
binding	O
,	O
Alexa	O
Fluor	O
488	O
-	O
labeled	O
TLF	O
was	O
incubated	O
with	O
trypanosomes	B-OG
at	O
4	O
°	O
C	O
for	O
1	O
h	O
,	O
cells	O
were	O
washed	O
,	O
and	O
then	O
cell	O
-	O
associated	O
fluorescence	O
was	O
measured	O
by	O
flow	O
cytometery	O
(	O
Figure	O
6A	O
).	O

Addition	O
of	O
Hb	B-GP
increased	O
binding	O
of	O
TLF	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
.	O
Maximum	O
stimulation	O
of	O
binding	O
was	O
reached	O
at	O
a	O
concentration	O
of	O
approximately	O
30	O
μg	O
/	O
ml	O
,	O
which	O
represents	O
a	O
1	O
:	O
10	O
molar	O
ratio	O
of	O
TLF	O
to	O
Hb	B-GP
,	O
assuming	O
an	O
average	O
molecular	O
mass	O
of	O
500	O
kDa	O
for	O
TLF	O
[	O
6	O
].	O

Addition	O
of	O
an	O
equimolar	O
concentration	O
of	O
Hp	B-GP
to	O
Hb	B-GP
severely	O
inhibited	O
binding	O
of	O
TLF	O
to	O
cells	O
,	O
resulting	O
in	O
binding	O
levels	O
similar	O
to	O
the	O
TLF	O
binding	O
observed	O
in	O
the	O
absence	O
of	O
Hb	B-GP
,	O
either	O
by	O
sequestering	O
all	O
available	O
Hb	B-GP
or	O
by	O
competition	O
for	O
the	O
trypanosome	B-OG
TLF	O
–	O
Hb	B-GP
receptor	O
.	O

These	O
experiments	O
suggest	O
that	O
Hb	B-GP
binding	O
to	O
TLF	O
stimulates	O
receptor	O
-	O
mediated	O
binding	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
,	O
and	O
that	O
TLF	O
–	O
Hb	B-GP
binding	O
to	O
the	O
receptor	O
is	O
specific	O
and	O
saturable	O
.	O

Hb	B-GP
Is	O
Required	O
for	O
Binding	O
and	O
Uptake	O
of	O
TLF	O

(	O
A	O
)	O
Alexa	O
Fluor	O
488	O
–	O
labeled	O
TLF	O
was	O
incubated	O
with	O
trypanosomes	B-OG
and	O
increasing	O
amounts	O
of	O
Hb	B-GP
.	O

Binding	O
was	O
measured	O
by	O
flow	O
cytometry	O
and	O
the	O
relative	O
mean	O
fluorescence	O
intensity	O
determined	O
following	O
binding	O
for	O
1	O
h	O
at	O
4	O
°	O
C	O
.	O

In	O
the	O
absence	O
of	O
Hp	B-GP
,	O
there	O
is	O
a	O
dose	O
-	O
dependent	O
increase	O
of	O
binding	O
of	O
Alexa	O
Fluor	O
488	O
–	O
labeled	O
TLF	O
in	O
the	O
presence	O
of	O
Hb	B-GP
(	O
closed	O
circles	O
).	O

Addition	O
of	O
Hp	B-GP
inhibited	O
TLF	O
–	O
Hb	B-GP
binding	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
(	O
open	O
circles	O
).	O

(	O
B	O
)	O
Uptake	O
of	O
TLF	O
–	O
Hb	B-GP
by	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
.	O

Trypanosomes	B-OG
were	O
pretreated	O
with	O
chloroquine	O
for	O
30	O
min	O
to	O
block	O
acidification	O
of	O
the	O
lysosome	O
and	O
activation	O
of	O
TLF	O
,	O
followed	O
by	O
the	O
addition	O
of	O
Alexa	O
Fluor	O
594	O
–	O
labeled	O
Hb	B-GP
and	O
Alexa	O
Fluor	O
488	O
–	O
labeled	O
TLF	O
.	O

Cells	O
were	O
incubated	O
for	O
an	O
additional	O
hour	O
at	O
37	O
°	O
C	O
.	O

The	O
TLF	O
–	O
Hb	B-GP
complex	O
was	O
endocytosed	O
and	O
traffics	O
to	O
the	O
lysosome	O
(	O
Figure	O
S2B	O
).	O

TLF	O
used	O
in	O
these	O
studies	O
was	O
purified	O
by	O
the	O
two	O
-	O
step	O
procedure	O
.	O

Killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
by	O
TLF	O
requires	O
trafficking	O
of	O
the	O
toxin	O
to	O
the	O
acidic	O
trypanosome	B-OG
lysosome	O
[	O
22	O
,	O
24	O
].	O

To	O
determine	O
whether	O
both	O
TLF	O
and	O
Hb	B-GP
co	O
-	O
localize	O
to	O
the	O
lysosome	O
,	O
Alexa	O
Fluor	O
488	O
–	O
conjugated	O
TLF	O
and	O
Alexa	O
Fluor	O
594	O
–	O
conjugated	O
Hb	B-GP
were	O
incubated	O
with	O
trypanosomes	B-OG
.	O

When	O
TLF	O
or	O
Hb	B-GP
alone	O
was	O
incubated	O
with	O
cells	O
,	O
no	O
intracellular	O
fluorescence	O
was	O
observed	O
(	O
Figure	O
S2A	O
).	O

Co	O
-	O
incubation	O
of	O
TLF	O
and	O
Hb	B-GP
resulted	O
in	O
the	O
rapid	O
uptake	O
and	O
intracellular	O
co	O
-	O
localization	O
to	O
the	O
lysosome	O
(	O
Figures	O
6B	O
and	O
S2B	O
).	O

These	O
results	O
illustrate	O
that	O
TLF	O
needs	O
to	O
be	O
associated	O
with	O
Hb	B-GP
in	O
order	O
to	O
be	O
endocytosed	O
by	O
T	O
.	O
b	O
.	O
brucei	O
,	O
and	O
that	O
both	O
TLF	O
and	O
Hb	B-GP
traffic	O
to	O
the	O
lysosome	O
of	O
the	O
cell	O
.	O

TLF	O
–	O
Hb	B-GP
Toxicity	O
to	O
Trypanosomes	B-OG

Heme	O
is	O
toxic	O
to	O
trypanosomes	B-OG
presumably	O
through	O
production	O
of	O
free	O
radicals	O
that	O
lead	O
to	O
lipid	O
peroxidation	O
of	O
trypanosome	B-OG
membranes	O
[	O
37	O
].	O

Previous	O
studies	O
suggested	O
that	O
the	O
toxicity	O
of	O
TLF	O
might	O
involve	O
lysosomal	O
membrane	O
peroxidation	O
[	O
15	O
,	O
24	O
,	O
30	O
].	O

Since	O
Hb	B-GP
traffics	O
with	O
TLF	O
to	O
the	O
trypanosome	B-OG
lysosome	O
,	O
we	O
asked	O
whether	O
Hb	B-GP
could	O
initiate	O
a	O
Fenton	O
-	O
like	O
reaction	O
.	O

Fenton	O
chemistry	O
requires	O
ferrous	O
iron	O
,	O
hydrogen	O
peroxide	O
,	O
and	O
low	O
pH	O
to	O
produce	O
hydroxyl	O
radicals	O
that	O
peroxidate	O
lipid	O
and	O
can	O
lead	O
to	O
membrane	O
degradation	O
and	O
cell	O
death	O
[	O
38	O
].	O

All	O
of	O
these	O
conditions	O
are	O
present	O
if	O
TLF	O
transports	O
Hb	B-GP
to	O
the	O
trypanosome	B-OG
lysosome	O
.	O

To	O
test	O
whether	O
TLF	O
–	O
Hb	B-GP
induces	O
a	O
Fenton	O
reaction	O
,	O
we	O
performed	O
lysis	O
assays	O
in	O
the	O
presence	O
of	O
the	O
iron	O
chelator	O
deferiprone	O
and	O
in	O
the	O
presence	O
of	O
the	O
free	O
radical	O
scavenger	O
N	O
,	O
N	O
′-	O
diphenyl	O
-	O
1	O
,	O
4	O
-	O
Benzenediamine	O
(	O
DPPD	O
)	O
(	O
Figure	O
7A	O
and	O
7B	O
).	O

Both	O
iron	O
chelation	O
and	O
the	O
scavenging	O
of	O
free	O
radicals	O
inhibited	O
lysis	O
by	O
about	O
50	O
%.	O

TLF	O
–	O
Hb	B-GP
Induces	O
Iron	O
-	O
Dependent	O
Lysosomal	O
Membrane	O
Breakdown	O

(	O
A	O
)	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
was	O
treated	O
with	O
increasing	O
concentration	O
of	O
the	O
iron	O
chelator	O
deferiprone	O
in	O
the	O
presence	O
(	O
closed	O
circles	O
)	O
and	O
absence	O
(	O
open	O
circles	O
)	O
of	O
TLF	O
–	O
Hb	B-GP
.	O

The	O
inhibition	O
of	O
trypanosome	B-OG
lysis	O
by	O
deferiprone	O
is	O
indicated	O
.	O

We	O
normalized	O
the	O
data	O
to	O
indicate	O
that	O
the	O
addition	O
of	O
no	O
deferiprone	O
gave	O
zero	O
inhibition	O
of	O
TLF	O
–	O
Hb	B-GP
lysis	O
after	O
2	O
h	O
at	O
37	O
°	O
C	O
.	O

(	O
B	O
)	O
Trypanosomes	B-OG
were	O
treated	O
with	O
increasing	O
concentrations	O
of	O
the	O
antioxidant	O
DPPD	O
in	O
the	O
presence	O
(	O
closed	O
circles	O
)	O
or	O
absence	O
(	O
open	O
circles	O
)	O
of	O
TLF	O
–	O
Hb	B-GP
.	O

The	O
inhibition	O
of	O
trypanosome	B-OG
lysis	O
by	O
DPPD	O
is	O
indicated	O
.	O

We	O
normalized	O
the	O
data	O
to	O
indicate	O
that	O
the	O
addition	O
of	O
no	O
DPPD	O
gave	O
zero	O
inhibition	O
of	O
TLF	O
–	O
Hb	B-GP
lysis	O
after	O
2	O
h	O
at	O
37	O
°	O
C	O
.	O

(	O
C	O
)	O
Effect	O
of	O
human	B-OG
serum	O
and	O
TLF	O
–	O
Hb	B-GP
treatment	O
on	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
lysosomal	O
membrane	O
structure	O
.	O

In	O
order	O
to	O
label	O
the	O
lysosome	O
with	O
a	O
size	O
-	O
selective	O
membrane	O
-	O
permeable	O
marker	O
,	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
was	O
pre	O
-	O
incubated	O
for	O
30	O
min	O
at	O
37	O
°	O
C	O
with	O
fluorescein	O
-	O
conjugated	O
dextrans	O
(	O
500	O
kDa	O
).	O

Normal	O
human	B-OG
serum	O
(	O
NHS	O
)	O
or	O
purified	O
TLF	O
–	O
Hb	B-GP
was	O
then	O
added	O
.	O

After	O
30	O
or	O
120	O
min	O
,	O
cells	O
were	O
formaldehyde	O
fixed	O
and	O
stained	O
with	O
anti	O
-	O
p67	B-GP
to	O
localize	O
the	O
lysosomal	O
membrane	O
.	O

After	O
treatment	O
with	O
normal	O
human	B-OG
serum	O
or	O
TLF	O
–	O
Hb	B-GP
for	O
30	O
min	O
,	O
dextrans	O
are	O
localized	O
to	O
a	O
single	O
cytoplasmic	O
structure	O
that	O
stained	O
with	O
an	O
antibody	O
against	O
the	O
lysosomal	O
marker	O
p67	B-GP
.	O

Trypanosomes	B-OG
treated	O
for	O
120	O
min	O
with	O
either	O
normal	O
human	B-OG
serum	O
or	O
TLF	O
–	O
Hb	B-GP
continued	O
to	O
show	O
p67	B-GP
staining	O
largely	O
restricted	O
to	O
a	O
single	O
structure	O
in	O
the	O
cell	O
,	O
but	O
the	O
500	O
-	O
kDa	O
dextrans	O
are	O
widely	O
distributed	O
in	O
the	O
cells	O
,	O
indicating	O
a	O
breakdown	O
in	O
lysosomal	O
membranes	O
.	O

TLF	O
used	O
in	O
these	O
studies	O
was	O
purified	O
by	O
the	O
two	O
-	O
step	O
procedure	O
.	O

To	O
further	O
investigate	O
the	O
mechanism	O
of	O
TLF	O
killing	O
,	O
we	O
returned	O
to	O
morphological	O
analysis	O
of	O
TLF	O
–	O
Hb	B-GP
-	O
treated	O
trypanosomes	B-OG
.	O

We	O
have	O
shown	O
that	O
TLF	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
results	O
in	O
cell	O
swelling	O
,	O
changes	O
in	O
overall	O
cell	O
morphology	O
,	O
and	O
eventually	O
lysis	O
(	O
Figure	O
2C	O
–	O
2F	O
)	O
[	O
24	O
].	O

Consistent	O
with	O
earlier	O
electron	O
microscopy	O
of	O
cells	O
treated	O
with	O
gold	O
-	O
conjugated	O
TLF	O
[	O
24	O
,	O
36	O
],	O
these	O
results	O
suggest	O
that	O
TLF	O
–	O
Hb	B-GP
causes	O
the	O
breakdown	O
of	O
lysosomal	O
membranes	O
.	O

To	O
determine	O
whether	O
TLF	O
–	O
Hb	B-GP
caused	O
extensive	O
lysosomal	O
membrane	O
breakdown	O
,	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
was	O
incubated	O
with	O
fluorescein	O
-	O
labeled	O
500	O
-	O
kDa	O
dextrans	O
,	O
which	O
trafficked	O
to	O
the	O
lysosome	O
by	O
bulk	O
phase	O
endocytosis	O
(	O
Figure	O
7C	O
).	O

After	O
the	O
cells	O
were	O
pre	O
-	O
loaded	O
with	O
dextrans	O
for	O
30	O
min	O
,	O
TLF	O
–	O
Hb	B-GP
or	O
human	B-OG
plasma	O
was	O
added	O
to	O
the	O
cells	O
.	O

After	O
30	O
min	O
of	O
exposure	O
,	O
the	O
fluorescent	O
dextrans	O
were	O
found	O
predominately	O
in	O
a	O
single	O
vesicle	O
co	O
-	O
localizing	O
with	O
the	O
lysosomal	O
membrane	O
marker	O
p67	B-GP
.	O

By	O
120	O
min	O
post	O
-	O
treatment	O
with	O
either	O
TLF	O
–	O
Hb	B-GP
or	O
human	B-OG
serum	O
,	O
the	O
dextrans	O
were	O
visible	O
throughout	O
the	O
cell	O
,	O
while	O
the	O
p67	B-GP
remained	O
predominantly	O
associated	O
with	O
the	O
singular	O
lysosome	O
.	O

Since	O
the	O
fluorescently	O
labeled	O
dextrans	O
escape	O
the	O
lysosome	O
in	O
the	O
presence	O
of	O
TLF	O
,	O
the	O
lysosomal	O
membrane	O
must	O
be	O
open	O
to	O
allow	O
release	O
of	O
the	O
large	O
dextrans	O
.	O

The	O
increased	O
intensity	O
of	O
the	O
fluorescein	O
-	O
labeled	O
dextrans	O
at	O
120	O
min	O
post	O
TLF	O
treatment	O
is	O
likely	O
due	O
to	O
their	O
release	O
into	O
the	O
neutral	O
pH	O
of	O
the	O
cytoplasm	O
[	O
39	O
].	O

Incubation	O
with	O
normal	O
human	B-OG
plasma	O
also	O
resulted	O
in	O
release	O
of	O
pre	O
-	O
loaded	O
dextrans	O
into	O
the	O
cytoplasm	O
prior	O
to	O
trypanosome	B-OG
lysis	O
(	O
Figure	O
7C	O
).	O

These	O
results	O
show	O
that	O
TLF	O
–	O
Hb	B-GP
causes	O
lysosomal	O
membrane	O
breakdown	O
prior	O
to	O
cell	O
lysis	O
,	O
as	O
does	O
normal	O
human	B-OG
serum	O
.	O

Discussion	O

We	O
have	O
identified	O
Hb	B-GP
as	O
a	O
critical	O
co	O
-	O
factor	O
in	O
the	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
by	O
human	B-OG
TLF	O
.	O

Analysis	O
of	O
purified	O
TLF	O
indicates	O
that	O
TLF	O
is	O
a	O
subclass	O
of	O
human	B-OG
HDL	O
containing	O
ApoA	B-GP
-	I-GP
1	I-GP
,	O
and	O
two	O
primate	B-OG
-	O
specific	O
apolipoproteins	B-GP
,	O
Hpr	B-GP
and	O
ApoL	B-GP
-	I-GP
1	I-GP
.	O

Hpr	B-GP
binds	O
human	B-OG
Hb	B-GP
with	O
high	O
affinity	O
,	O
and	O
the	O
formation	O
of	O
the	O
TLF	O
–	O
Hb	B-GP
complex	O
enhances	O
binding	O
to	O
the	O
trypanosome	B-OG
TLF	O
receptor	O
and	O
triggers	O
lysosome	O
breakdown	O
by	O
an	O
iron	O
-	O
dependent	O
,	O
free	O
radical	O
–	O
mediated	O
pathway	O
.	O

Despite	O
the	O
role	O
of	O
Hb	B-GP
in	O
TLF	O
binding	O
and	O
toxicity	O
,	O
no	O
Hb	B-GP
is	O
detected	O
in	O
TLF	O
prepared	O
from	O
healthy	O
human	B-OG
donors	O
.	O

This	O
indicates	O
that	O
activation	O
of	O
TLF	O
occurs	O
upon	O
the	O
release	O
of	O
free	O
Hb	B-GP
in	O
the	O
circulation	O
during	O
intravascular	O
hemolysis	O
.	O

TLF	O
Contains	O
Both	O
Hpr	B-GP
and	O
ApoL	B-GP
-	I-GP
1	I-GP

A	O
major	O
question	O
concerning	O
the	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
by	O
human	B-OG
serum	O
has	O
centered	O
around	O
whether	O
the	O
toxin	O
was	O
Hpr	B-GP
,	O
ApoL	B-GP
-	I-GP
1	I-GP
,	O
or	O
both	O
of	O
these	O
proteins	O
[	O
10	O
,	O
14	O
,	O
25	O
,	O
40	O
].	O

In	O
this	O
paper	O
,	O
the	O
protein	O
composition	O
of	O
human	B-OG
TLF	O
was	O
determined	O
by	O
western	O
blot	O
and	O
LC	O
-	O
MS	O
/	O
MS	O
.	O

While	O
several	O
studies	O
have	O
previously	O
identified	O
protein	O
components	O
of	O
this	O
subclass	O
of	O
trypanolytic	O
human	B-OG
HDL	O
,	O
all	O
have	O
used	O
samples	O
that	O
have	O
been	O
subjected	O
to	O
lengthy	O
purification	O
protocols	O
involving	O
high	O
-	O
salt	O
density	O
ultracentrifugation	O
[	O
6	O
,	O
34	O
].	O

We	O
were	O
concerned	O
that	O
these	O
procedures	O
would	O
dissociate	O
proteins	O
from	O
TLF	O
that	O
might	O
provide	O
information	O
on	O
the	O
native	O
composition	O
of	O
this	O
innate	O
killing	O
factor	O
and	O
on	O
the	O
mechanism	O
of	O
killing	O
.	O

When	O
TLF	O
was	O
isolated	O
directly	O
from	O
freshly	O
prepared	O
human	B-OG
plasma	O
by	O
immunoaffinity	O
chromatography	O
with	O
antibodies	O
against	O
either	O
human	B-OG
ApoL	B-GP
-	I-GP
1	I-GP
or	O
Hpr	B-GP
,	O
the	O
major	O
protein	O
components	O
were	O
identical	O
.	O

The	O
specific	O
activity	O
and	O
morphology	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
lysis	O
was	O
also	O
identical	O
.	O

This	O
analysis	O
indicates	O
that	O
Hpr	B-GP
and	O
ApoL	B-GP
-	I-GP
1	I-GP
are	O
assembled	O
into	O
the	O
same	O
HDL	O
particle	O
and	O
that	O
the	O
amount	O
of	O
Hpr	B-GP
or	O
ApoL	B-GP
-	I-GP
1	I-GP
found	O
free	O
in	O
the	O
human	B-OG
circulatory	O
system	O
is	O
extremely	O
low	O
.	O

Thus	O
,	O
the	O
native	O
toxin	O
in	O
humans	B-OG
is	O
not	O
ApoL	B-GP
-	I-GP
1	I-GP
or	O
Hpr	B-GP
alone	O
but	O
is	O
an	O
HDL	O
particle	O
containing	O
both	O
of	O
these	O
apoliproteins	O
.	O

This	O
is	O
consistent	O
with	O
previous	O
studies	O
showing	O
that	O
Hpr	B-GP
and	O
ApoL	B-GP
-	I-GP
1	I-GP
were	O
present	O
in	O
the	O
same	O
HDL	O
and	O
both	O
were	O
required	O
for	O
maximal	O
trypanosome	B-OG
killing	O
[	O
14	O
].	O

In	O
addition	O
,	O
recent	O
analysis	O
of	O
the	O
trypanolytic	O
activity	O
of	O
human	B-OG
serum	O
from	O
individuals	O
deficient	O
in	O
either	O
ApoL	B-GP
-	I-GP
1	I-GP
or	O
Hpr	B-GP
suggests	O
that	O
both	O
proteins	O
play	O
distinct	O
and	O
important	O
roles	O
to	O
achieve	O
maximal	O
lytic	O
activity	O
[	O
40	O
].	O

The	O
Role	O
of	O
Hb	B-GP
in	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
Killing	O
by	O
TLF	O

Several	O
early	O
studies	O
reported	O
that	O
TLF	O
did	O
not	O
bind	O
Hb	B-GP
[	O
12	O
,	O
30	O
],	O
but	O
recently	O
it	O
was	O
shown	O
that	O
recombinant	O
Hpr	B-GP
bound	O
Hb	B-GP
with	O
high	O
affinity	O
[	O
31	O
].	O

Consistent	O
with	O
these	O
results	O
,	O
we	O
found	O
that	O
purified	O
native	O
TLF	O
and	O
purified	O
native	O
Hpr	B-GP
bound	O
Hb	B-GP
with	O
high	O
affinity	O
(	O
Figure	O
3	O
).	O

Nevertheless	O
,	O
MS	O
analysis	O
failed	O
to	O
detect	O
Hb	B-GP
as	O
a	O
component	O
of	O
purified	O
TLF	O
,	O
most	O
likely	O
because	O
the	O
low	O
levels	O
of	O
Hb	B-GP
that	O
are	O
released	O
into	O
the	O
plasma	O
of	O
individuals	O
with	O
normal	O
erythrocyte	O
turnover	O
are	O
instantly	O
bound	O
by	O
Hp	B-GP
,	O
which	O
is	O
present	O
in	O
large	O
excess	O
compared	O
to	O
Hpr	B-GP
(	O
the	O
concentration	O
of	O
Hp	B-GP
is	O
roughly	O
10	O
-	O
to	O
100	O
-	O
fold	O
higher	O
than	O
Hpr	B-GP
in	O
normal	O
human	B-OG
serum	O
)	O
[	O
12	O
,	O
31	O
].	O

The	O
rapidly	O
formed	O
Hp	B-GP
–	O
Hb	B-GP
complex	O
is	O
then	O
removed	O
by	O
CD163	B-GP
.	O

Hence	O
,	O
despite	O
its	O
high	O
affinity	O
for	O
Hb	B-GP
,	O
Hpr	B-GP
may	O
only	O
compete	O
well	O
for	O
free	O
Hb	B-GP
under	O
physiological	O
conditions	O
where	O
Hp	B-GP
levels	O
were	O
low	O
.	O

As	O
we	O
discuss	O
below	O
,	O
infection	B-DS
by	O
trypanosomes	B-OG
causes	O
declines	O
in	O
Hp	B-GP
levels	O
in	O
animals	B-OG
[	O
41	O
–	O
44	O
].	O

In	O
order	O
to	O
evaluate	O
the	O
role	O
of	O
Hb	B-GP
as	O
a	O
co	O
-	O
factor	O
in	O
TLF	O
-	O
mediated	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
,	O
we	O
developed	O
an	O
in	O
vitro	O
lysis	O
assay	O
without	O
FBS	O
,	O
a	O
standard	O
component	O
of	O
our	O
in	O
vitro	O
trypanosome	B-OG
lysis	O
assays	O
,	O
and	O
a	O
source	O
of	O
contaminating	O
free	O
Hb	B-GP
(	O
Figure	O
4A	O
).	O

We	O
found	O
that	O
substitution	O
of	O
BSA	O
for	O
FBS	O
in	O
lysis	O
assays	O
dramatically	O
reduced	O
the	O
activity	O
of	O
TLF	O
,	O
but	O
that	O
maximal	O
activity	O
could	O
be	O
restored	O
by	O
addition	O
of	O
human	B-OG
Hb	B-GP
to	O
the	O
assays	O
(	O
Figure	O
5A	O
).	O

Hb	B-GP
stimulation	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
killing	O
by	O
TLF	O
is	O
due	O
to	O
both	O
enhanced	O
binding	O
to	O
the	O
trypanosome	B-OG
cell	O
surface	O
receptor	O
for	O
TLF	O
and	O
direct	O
cytotoxicity	O
of	O
lysosomally	O
localized	O
Hb	B-GP
(	O
Figures	O
6	O
and	O
S2B	O
).	O

The	O
basis	O
for	O
the	O
enhanced	O
trypanosome	B-OG
receptor	O
recognition	O
of	O
the	O
TLF	O
–	O
Hb	B-GP
complex	O
is	O
unknown	O
,	O
but	O
the	O
mammalian	O
CD163	B-GP
receptor	I-GP
shows	O
a	O
similar	O
binding	O
preference	O
for	O
the	O
Hp	B-GP
–	O
Hb	B-GP
complex	O
[	O
32	O
,	O
33	O
].	O

Our	O
studies	O
show	O
that	O
not	O
only	O
is	O
trypanosome	B-OG
binding	O
of	O
TLF	O
stimulated	O
by	O
Hb	B-GP
association	O
but	O
that	O
the	O
trafficking	O
of	O
both	O
TLF	O
and	O
Hb	B-GP
to	O
the	O
lysosome	O
is	O
enhanced	O
(	O
Figures	O
6	O
and	O
S2B	O
).	O

The	O
mechanism	O
of	O
TLF	O
-	O
induced	O
cell	O
lysis	O
is	O
controversial	O
,	O
but	O
studies	O
from	O
our	O
lab	O
have	O
shown	O
that	O
both	O
freshly	O
prepared	O
normal	O
human	B-OG
serum	O
and	O
TLF	O
produce	O
peroxidated	O
lipids	O
in	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
,	O
suggesting	O
a	O
mechanism	O
of	O
killing	O
[	O
30	O
].	O

Based	O
on	O
the	O
findings	O
reported	O
here	O
,	O
we	O
propose	O
that	O
Hb	B-GP
,	O
bound	O
to	O
Hpr	B-GP
within	O
the	O
TLF	O
particle	O
,	O
contributes	O
directly	O
to	O
the	O
established	O
ApoL	B-GP
-	I-GP
1	I-GP
-	O
mediated	O
toxicity	O
of	O
TLF	O
[	O
8	O
,	O
10	O
,	O
28	O
,	O
29	O
,	O
40	O
].	O

Following	O
binding	O
and	O
lysosomal	O
localization	O
,	O
Hb	B-GP
may	O
contribute	O
iron	O
that	O
reacts	O
with	O
H2O2	O
in	O
a	O
Fenton	O
-	O
based	O
reaction	O
that	O
leads	O
to	O
free	O
radical	O
formation	O
and	O
lysosomal	O
membrane	O
breakdown	O
(	O
Figure	O
7	O
)	O
[	O
9	O
,	O
15	O
,	O
24	O
,	O
45	O
].	O

Interestingly	O
,	O
earlier	O
studies	O
using	O
an	O
in	O
vitro	O
TLF	O
assay	O
containing	O
0	O
.	O
2	O
%	O
BSA	O
,	O
and	O
no	O
Hb	B-GP
,	O
did	O
not	O
kill	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
by	O
a	O
Fenton	O
-	O
based	O
mechanism	O
([	O
46	O
]).	O

The	O
morphological	O
analysis	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
treated	O
with	O
TLF	O
–	O
Hb	B-GP
showed	O
cells	O
swelling	O
into	O
a	O
kite	O
-	O
shape	O
prior	O
to	O
the	O
bursting	O
.	O

We	O
were	O
able	O
to	O
directly	O
test	O
the	O
permeability	O
of	O
the	O
lysosomal	O
membrane	O
following	O
TLF	O
–	O
Hb	B-GP
treatment	O
by	O
pre	O
-	O
loading	O
cells	O
with	O
defined	O
size	O
(	O
500	O
kDa	O
)	O
fluorescein	O
-	O
conjugated	O
dextrans	O
then	O
adding	O
TLF	O
–	O
Hb	B-GP
(	O
Figure	O
7C	O
).	O

Prior	O
to	O
lysis	O
,	O
dextrans	O
were	O
seen	O
throughout	O
the	O
cytoplasm	O
indicating	O
that	O
TLF	O
–	O
Hb	B-GP
caused	O
the	O
lysosomal	O
membrane	O
to	O
breakdown	O
,	O
releasing	O
the	O
large	O
fluorescein	O
-	O
conjugated	O
dextrans	O
.	O

Based	O
on	O
the	O
pharmacological	O
inhibition	O
of	O
TLF	O
–	O
Hb	B-GP
killing	O
by	O
deferiprone	O
and	O
DPPD	O
,	O
we	O
postulate	O
that	O
membrane	O
lipid	O
peroxidation	O
plays	O
a	O
major	O
role	O
in	O
lysosomal	O
membrane	O
breakdown	O
followed	O
by	O
cell	O
lysis	O
.	O

This	O
does	O
not	O
argue	O
against	O
a	O
role	O
of	O
ApoL	B-GP
-	I-GP
1	I-GP
in	O
TLF	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
[	O
8	O
,	O
10	O
,	O
19	O
,	O
25	O
–	O
28	O
].	O

Recombinant	O
and	O
native	O
ApoL	B-GP
-	I-GP
1	I-GP
are	O
toxic	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
and	O
the	O
evidence	O
that	O
it	O
creates	O
ion	O
pores	O
in	O
trypanosome	B-OG
membranes	O
is	O
convincing	O
[	O
10	O
].	O

Activation	O
of	O
the	O
Innate	O
TLF	O
Response	O
by	O
Hb	B-GP

Does	O
Hb	B-GP
stimulation	O
of	O
TLF	O
binding	O
and	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
occur	O
in	O
humans	B-OG
,	O
and	O
is	O
this	O
important	O
in	O
protection	O
against	O
these	O
parasites	O
?	O

In	O
vitro	O
studies	O
reported	O
here	O
leave	O
little	O
doubt	O
that	O
Hb	B-GP
association	O
with	O
Hpr	B-GP
enhances	O
TLF	O
binding	O
to	O
and	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
.	O

However	O
,	O
when	O
TLF	O
is	O
isolated	O
from	O
normal	O
human	B-OG
donors	O
,	O
Hb	B-GP
is	O
absent	O
.	O

This	O
apparent	O
paradox	O
can	O
be	O
explained	O
when	O
one	O
carefully	O
considers	O
the	O
early	O
physiological	O
events	O
associated	O
with	O
trypanosome	B-DS
infection	I-DS
.	O

During	O
infection	B-DS
of	O
animals	B-OG
by	O
African	O
trypanosomes	B-OG
,	O
there	O
is	O
substantial	O
hemolysis	O
,	O
and	O
in	O
some	O
cases	O
,	O
the	O
hematocrit	O
can	O
drop	O
by	O
as	O
much	O
as	O
50	O
%	O
[	O
42	O
–	O
44	O
].	O

The	O
exact	O
cause	O
of	O
hemolysis	O
is	O
not	O
known	O
,	O
but	O
blood	O
cell	O
production	O
increases	O
during	O
infection	B-DS
,	O
so	O
the	O
decrease	O
in	O
hematocrit	O
is	O
not	O
due	O
to	O
decreased	O
erythrocyte	O
production	O
but	O
rather	O
to	O
hemolysis	O
[	O
47	O
].	O

Hemolysis	O
results	O
in	O
the	O
release	O
of	O
large	O
quantities	O
of	O
Hb	B-GP
,	O
most	O
of	O
which	O
will	O
be	O
bound	O
and	O
removed	O
by	O
circulating	O
Hp	B-GP
[	O
42	O
,	O
48	O
].	O

During	O
a	O
trypanosome	B-OG
-	O
induced	O
acute	O
phase	O
response	O
in	O
calves	O
,	O
levels	O
of	O
Hp	B-GP
are	O
reduced	O
to	O
undetectable	O
levels	O
8	O
d	O
post	O
-	O
infection	B-DS
,	O
presumably	O
due	O
to	O
removal	O
of	O
Hp	B-GP
from	O
the	O
circulation	O
after	O
Hp	B-GP
–	O
Hb	B-GP
complexes	O
have	O
formed	O
[	O
42	O
].	O

In	O
mice	B-OG
,	O
Hp	B-GP
levels	O
initially	O
increase	O
after	O
trypanosome	B-DS
infection	I-DS
,	O
and	O
then	O
decline	O
[	O
48	O
,	O
49	O
].	O

Consistent	O
with	O
the	O
studies	O
in	O
animals	B-OG
,	O
human	B-OG
trypanosome	B-DS
infections	I-DS
also	O
result	O
in	O
substantial	O
hemolysis	O
and	O
release	O
of	O
free	O
Hb	B-GP
[	O
50	O
].	O

While	O
Hp	B-GP
initially	O
binds	O
all	O
free	O
Hb	B-GP
,	O
the	O
clearance	O
of	O
the	O
Hp	B-GP
–	O
Hb	B-GP
complex	O
would	O
result	O
in	O
a	O
significant	O
drop	O
in	O
Hp	B-GP
levels	O
to	O
the	O
point	O
where	O
Hpr	B-GP
would	O
become	O
a	O
major	O
Hb	B-GP
-	O
binding	O
protein	O
.	O

Thus	O
,	O
as	O
Hp	B-GP
levels	O
decrease	O
and	O
TLF	O
–	O
Hb	B-GP
levels	O
increase	O
,	O
there	O
may	O
be	O
a	O
substantial	O
stimulation	O
of	O
TLF	O
activity	O
.	O

A	O
second	O
factor	O
may	O
influence	O
the	O
formation	O
of	O
TLF	O
–	O
Hb	B-GP
complexes	O
in	O
the	O
circulation	O
of	O
humans	B-OG
.	O

Previous	O
studies	O
have	O
reported	O
the	O
incidence	O
of	O
both	O
genetic	O
and	O
phenotypic	O
ahaptoglobinemia	B-DS
in	O
African	O
populations	O
,	O
perhaps	O
due	O
to	O
reduced	O
severity	O
of	O
malaria	B-DS
infection	I-DS
in	O
Hp	B-GP
-	O
negative	O
individuals	O
[	O
51	O
–	O
53	O
].	O

In	O
some	O
regions	O
where	O
malarial	B-DS
infections	I-DS
are	O
prevalent	O
,	O
the	O
frequency	O
of	O
ahaptoglobinemic	O
individuals	O
can	O
be	O
as	O
high	O
as	O
48	O
%	O
[	O
51	O
,	O
54	O
,	O
55	O
].	O

In	O
these	O
individuals	O
,	O
Hpr	B-GP
-	O
associated	O
TLF	O
could	O
be	O
the	O
primary	O
Hb	B-GP
-	O
binding	O
protein	O
.	O

We	O
have	O
previously	O
postulated	O
that	O
ApoL	B-GP
-	I-GP
1	I-GP
and	O
Hpr	B-GP
act	O
synergistically	O
in	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
killing	O
[	O
14	O
].	O

We	O
now	O
propose	O
an	O
avenue	O
by	O
which	O
TLF	O
activity	O
is	O
increased	O
when	O
Hpr	B-GP
and	O
ApoL	B-GP
-	I-GP
1	I-GP
are	O
present	O
in	O
the	O
same	O
HDL	O
particle	O
.	O

First	O
,	O
Hb	B-GP
binding	O
to	O
TLF	O
stimulates	O
endocytosis	O
of	O
TLF	O
–	O
Hb	B-GP
by	O
increased	O
receptor	O
affinity	O
.	O

Second	O
,	O
TLF	O
–	O
Hb	B-GP
provides	O
iron	O
that	O
initiates	O
Fenton	O
chemistry	O
,	O
leading	O
to	O
lysosomal	O
membrane	O
breakdown	O
while	O
ApoL	B-GP
-	I-GP
1	I-GP
forms	O
pores	O
in	O
membranes	O
,	O
disrupting	O
the	O
ability	O
of	O
the	O
cell	O
to	O
regulate	O
osmosis	O
.	O

The	O
results	O
presented	O
here	O
support	O
the	O
hypothesis	O
that	O
formation	O
of	O
the	O
Hpr	B-GP
–	O
Hb	B-GP
complex	O
within	O
the	O
TLF	O
particle	O
plays	O
a	O
role	O
in	O
human	B-OG
serum	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
.	O

Hb	B-GP
seems	O
to	O
induce	O
increased	O
binding	O
of	O
TLF	O
to	O
the	O
parasite	O
and	O
contributes	O
directly	O
to	O
toxicity	O
in	O
the	O
lysosome	O
.	O

This	O
suggests	O
that	O
parasite	O
-	O
induced	O
hemolysis	O
stimulates	O
innate	O
immunity	O
against	O
the	O
parasite	O
in	O
humans	B-OG
.	O

Materials	O
and	O
Methods	O

Human	B-OG
serum	O
preparation	O
and	O
immunoaffinity	O
chromatography	O
.	O

Blood	O
was	O
collected	O
from	O
healthy	O
human	B-OG
volunteers	O
and	O
was	O
maintained	O
on	O
ice	O
or	O
at	O
4	O
°	O
C	O
throughout	O
the	O
fractionation	O
procedure	O
.	O

Plasma	O
was	O
separated	O
from	O
blood	O
cells	O
by	O
centrifugation	O
at	O
3	O
,	O
500	O
rpm	O
in	O
a	O
SLA	O
-	O
3000	O
rotor	O
(	O
Sorvall	O
,	O
http	O
://	O
www	O
.	O
thermo	O
.	O
com	O
/)	O
for	O
10	O
min	O
at	O
4	O
°	O
C	O
.	O

The	O
plasma	O
supernate	O
was	O
removed	O
and	O
re	O
-	O
centrifuged	O
in	O
an	O
SS	O
-	O
34	O
rotor	O
(	O
Sorvall	O
)	O
at	O
9	O
,	O
500	O
rpm	O
for	O
10	O
min	O
at	O
4	O
°	O
C	O
to	O
remove	O
any	O
residual	O
blood	O
cells	O
.	O

Plasma	O
was	O
kept	O
on	O
ice	O
for	O
no	O
more	O
than	O
3	O
h	O
prior	O
to	O
antibody	O
affinity	O
chromatography	O
.	O

Monoclonal	O
antibodies	O
were	O
raised	O
against	O
TLF	O
particles	O
,	O
and	O
the	O
specificity	O
of	O
the	O
antibodies	O
for	O
Hpr	B-GP
and	O
ApoL	B-GP
-	I-GP
1	I-GP
has	O
been	O
previously	O
described	O
[	O
14	O
].	O

The	O
monoclonal	O
antibodies	O
were	O
purified	O
from	O
mouse	B-OG
ascites	O
by	O
Protein	B-GP
G	I-GP
affinity	O
chromatography	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
recommendations	O
(	O
Pierce	O
Biotechnology	O
,	O
http	O
://	O
www	O
.	O
piercenet	O
.	O
com	O
/).	O

Affinity	O
-	O
purified	O
polyclonal	O
antibodies	O
against	O
human	B-OG
ApoA	B-GP
-	I-GP
1	I-GP
were	O
purchased	O
from	O
Rockland	O
Immunochemicals	O
(	O
http	O
://	O
www	O
.	O
rockland	O
-	O
inc	O
.	O
com	O
/).	O

The	O
three	O
antibodies	O
(	O
200	O
μg	O
)	O
were	O
coupled	O
to	O
Affigel	O
15	O
(	O
50	O
μl	O
)	O
(	O
Bio	O
-	O
Rad	O
,	O
http	O
://	O
www	O
.	O
bio	O
-	O
rad	O
.	O
com	O
/)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
recommendations	O
and	O
100	O
μl	O
of	O
the	O
AffiGel	O
slurry	O
(	O
corresponding	O
to	O
approximately	O
200	O
μg	O
of	O
antibody	O
)	O
was	O
transferred	O
to	O
1	O
.	O
5	O
-	O
ml	O
microfuge	O
tubes	O
.	O

Human	B-OG
plasma	O
(	O
1	O
ml	O
)	O
was	O
added	O
to	O
each	O
antibody	O
containing	O
tube	O
and	O
incubated	O
for	O
30	O
min	O
at	O
4	O
°	O
C	O
on	O
a	O
rotating	O
platform	O
.	O

AffiGel	O
/	O
antibody	O
resin	O
was	O
recovered	O
by	O
centrifugation	O
for	O
90	O
s	O
at	O
1	O
,	O
000g	O
at	O
4	O
°	O
C	O
and	O
the	O
immuno	O
-	O
depleted	O
plasma	O
discarded	O
.	O

Additional	O
1	O
-	O
ml	O
samples	O
of	O
plasma	O
were	O
added	O
to	O
each	O
sample	O
and	O
immuno	O
-	O
depletion	O
steps	O
were	O
repeated	O
until	O
5	O
ml	O
of	O
plasma	O
had	O
been	O
treated	O
.	O

The	O
AffiGel	O
/	O
antibody	O
resin	O
was	O
then	O
washed	O
seven	O
times	O
with	O
1	O
ml	O
of	O
PBSE	O
(	O
137	O
mM	O
NaCl	O
,	O
2	O
.	O
7	O
mM	O
KCl	O
,	O
10	O
mM	O
Na2HPO4	O
,	O
10	O
mM	O
KH2PO4	O
,	O
3	O
mM	O
EDTA	O
).	O

Following	O
the	O
washes	O
,	O
the	O
AffiGel	O
/	O
antibody	O
resin	O
was	O
treated	O
with	O
200	O
μl	O
of	O
100mM	O
glycine	O
(	O
pH	O
2	O
.	O
0	O
)	O
for	O
5	O
min	O
at	O
4	O
°	O
C	O
to	O
elute	O
bound	O
human	B-OG
plasma	O
proteins	O
.	O

The	O
eluate	O
was	O
dialyzed	O
against	O
PBSE	O
at	O
4	O
°	O
C	O
prior	O
to	O
analysis	O
for	O
protein	O
composition	O
and	O
trypanolytic	O
activity	O
.	O

Western	O
blot	O
analysis	O
of	O
TLF	O
.	O

Following	O
elution	O
from	O
anti	O
-	O
ApoL	B-GP
-	I-GP
1	I-GP
,	O
anti	O
-	O
Hpr	B-GP
,	O
and	O
anti	O
-	O
ApoA	B-GP
-	I-GP
1	I-GP
AffiGel	O
resin	O
,	O
samples	O
were	O
precipitated	O
with	O
100	O
%	O
ice	O
-	O
cold	O
acetone	O
and	O
proteins	O
were	O
separated	O
on	O
a	O
10	O
%	O
SDS	O
-	O
polyacrylamide	O
gel	O
under	O
non	O
-	O
denaturing	O
conditions	O
.	O

Gels	O
were	O
either	O
Coomassie	O
stained	O
or	O
western	O
blotted	O
onto	O
nitrocellulose	O
.	O

For	O
western	O
blot	O
analysis	O
,	O
membranes	O
were	O
blocked	O
with	O
5	O
%	O
milk	O
in	O
TTBS	O
(	O
20mM	O
Tris	O
,	O
500mM	O
NaCl	O
,	O
0	O
.	O
05	O
%	O
Tween	O
-	O
20	O
)	O
and	O
were	O
probed	O
with	O
antibodies	O
diluted	O
with	O
5	O
%	O
milk	O
in	O
TTBS	O
:	O
Hpr	B-GP
(	O
1	O
:	O
10	O
,	O
000	O
),	O
ApoL	B-GP
-	I-GP
1	I-GP
(	O
1	O
:	O
10	O
,	O
000	O
),	O
ApoA	B-GP
-	I-GP
1	I-GP
(	O
1	O
:	O
5000	O
),	O
Hb	B-GP
(	O
1	O
:	O
2000	O
),	O
and	O
transferrin	B-GP
-	O
Hrp	O
(	O
1	O
:	O
2000	O
).	O

After	O
incubation	O
with	O
secondary	O
antibodies	O
(	O
goat	B-OG
anti	O
-	O
rabbit	B-OG
and	O
goat	B-OG
anti	O
-	O
mouse	B-OG
at	O
1	O
:	O
10	O
,	O
000	O
in	O
all	O
cases	O
except	O
transferrin	B-GP
),	O
(	O
Pierce	O
Biotechnology	O
)	O
proteins	O
were	O
detected	O
following	O
reaction	O
with	O
ECL	O
Plus	O
(	O
GE	O
Healthcare	O
,	O
http	O
://	O
www	O
.	O
gelifesciences	O
.	O
com	O
/)	O
and	O
were	O
visualized	O
by	O
autoradiography	O
.	O

Protein	O
concentrations	O
were	O
determined	O
by	O
Bradford	O
assay	O
(	O
Bio	O
-	O
Rad	O
).	O

LC	O
-	O
MS	O
/	O
MS	O
.	O

For	O
mass	O
spectroscopy	O
analysis	O
,	O
protein	O
bands	O
were	O
excised	O
from	O
Coomassie	O
-	O
stained	O
gels	O
,	O
trypsin	B-GP
digested	O
,	O
and	O
fractionated	O
by	O
reverse	O
phase	O
chromatography	O
(	O
C	O
-	O
18	O
PepMap100	O
,	O
75	O
um	O
ID	O
×	O
15	O
mm	O
,	O
3	O
-	O
um	O
particle	O
size	O
,	O
LC	O
Packings	O
/	O
Dionex	O
,	O
http	O
://	O
www	O
.	O
dionex	O
.	O
com	O
/).	O

The	O
column	O
eluate	O
was	O
introduced	O
onto	O
a	O
QSTAR	O
XL	O
mass	O
spectrometer	O
(	O
Applied	O
Biosystems	O
,	O
http	O
://	O
www	O
.	O
appliedbiosystems	O
.	O
com	O
/,	O
and	O
MDS	O
Sciex	O
,	O
http	O
://	O
www	O
.	O
mdssciex	O
.	O
com	O
/)	O
by	O
electrospray	O
ionization	O
.	O

Ions	O
were	O
selected	O
and	O
fragmented	O
using	O
a	O
standard	O
information	O
dependent	O
acquisition	O
method	O
.	O

An	O
ion	O
had	O
to	O
be	O
assigned	O
a	O
charge	O
in	O
the	O
+	O
2	O
to	O
+	O
4	O
range	O
to	O
be	O
considered	O
a	O
candidate	O
for	O
fragmentation	O
.	O

Identification	O
of	O
proteins	O
was	O
performed	O
using	O
ProID	O
software	O
(	O
Applied	O
Biosystems	O
)	O
and	O
experimental	O
spectra	O
were	O
matched	O
against	O
in	O
silica	O
trypsinizations	O
of	O
the	O
NCBI	O
non	O
-	O
redundant	O
database	O
.	O

T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
cultivation	O
and	O
lysis	O
assays	O
.	O

Bloodstream	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
(	O
Lister	O
strain	O
427	O
,	O
MiTat	O
1	O
.	O
2	O
)	O
were	O
cultured	O
in	O
HMI	O
-	O
9	O
media	O
supplemented	O
with	O
10	O
%	O
FBS	O
(	O
heat	O
inactivated	O
,	O
58	O
°	O
C	O
for	O
30	O
min	O
).	O

Trypanolytic	O
activity	O
of	O
fractionated	O
HDLs	O
was	O
determined	O
by	O
in	O
vitro	O
microscopic	O
assays	O
as	O
previously	O
described	O
[	O
6	O
].	O

All	O
samples	O
were	O
dialyzed	O
exhaustively	O
against	O
PBSE	O
,	O
at	O
4	O
°	O
C	O
,	O
prior	O
to	O
incubation	O
with	O
the	O
parasites	O
(	O
1	O
×	O
107	O
cells	O
per	O
300	O
-	O
μl	O
assay	O
)	O
for	O
2	O
h	O
at	O
37	O
°	O
C	O
in	O
HMI	O
-	O
9	O
media	O
containing	O
10	O
%	O
FBS	O
.	O

To	O
determine	O
whether	O
FBS	O
contributed	O
to	O
TLF	O
-	O
mediated	O
killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
some	O
lysis	O
assays	O
contained	O
1	O
%	O
BSA	O
and	O
1	O
%	O
glucose	O
without	O
intact	O
FBS	O
.	O

Hb	B-GP
A0	O
and	O
Hp	B-GP
1	O
–	O
1	O
were	O
obtained	O
from	O
Sigma	O
-	O
Aldrich	O
(	O
http	O
://	O
www	O
.	O
sigmaaldrich	O
.	O
com	O
/).	O

In	O
this	O
paper	O
and	O
in	O
previous	O
papers	O
,	O
we	O
define	O
a	O
lytic	O
unit	O
of	O
activity	O
as	O
the	O
amount	O
of	O
material	O
necessary	O
to	O
lyse	O
50	O
%	O
of	O
the	O
parasites	O
,	O
in	O
a	O
300	O
-	O
μl	O
assay	O
containing	O
1	O
×	O
107	O
cells	O
after	O
incubation	O
for	O
2	O
h	O
at	O
37	O
°	O
C	O
[	O
8	O
].	O

The	O
iron	O
chelator	O
1	O
,	O
2	O
-	O
dimethyl	O
-	O
3	O
-	O
hydroxypyrid	O
-	O
4	O
-	O
one	O
(	O
deferriprone	O
)	O
was	O
used	O
in	O
the	O
chelation	O
inhibition	O
studies	O
and	O
DPPD	O
was	O
the	O
antioxidant	O
used	O
.	O

Cell	O
imaging	O
.	O

Lysis	O
of	O
live	O
parasites	O
was	O
visualized	O
by	O
the	O
addition	O
of	O
TLF	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
imbedded	O
in	O
1	O
%	O
low	O
melting	O
point	O
agarose	O
(	O
Sigma	O
)	O
made	O
with	O
PBSE	O
containing	O
1	O
%	O
glucose	O
following	O
2	O
h	O
of	O
incubation	O
at	O
37	O
°	O
C	O
.	O

Samples	O
were	O
prepared	O
for	O
microscopy	O
by	O
the	O
addition	O
of	O
10	O
μl	O
of	O
low	O
melting	O
point	O
agarose	O
to	O
10	O
μls	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
at	O
a	O
final	O
concentration	O
of	O
1	O
×	O
107	O
/	O
ml	O
.	O

Both	O
the	O
agarose	O
and	O
trypanosome	B-OG
samples	O
were	O
maintained	O
at	O
37	O
°	O
C	O
,	O
gently	O
mixed	O
,	O
and	O
transferred	O
to	O
a	O
microscope	O
slide	O
.	O

To	O
further	O
reduce	O
the	O
motility	O
of	O
trypanosomes	B-OG
,	O
the	O
slide	O
was	O
chilled	O
at	O
4	O
°	O
C	O
for	O
10	O
min	O
and	O
then	O
imaged	O
using	O
a	O
motorized	O
Zeiss	O
Axioplan2	O
and	O
an	O
MRm	O
camera	O
interfaced	O
with	O
the	O
Axiovisions	O
4	O
.	O
4	O
software	O
(	O
Zeiss	O
,	O
http	O
://	O
www	O
.	O
zeiss	O
.	O
com	O
/).	O

Methanol	O
-	O
fixed	O
samples	O
were	O
also	O
visualized	O
.	O

Cells	O
incubated	O
with	O
TLF	O
samples	O
as	O
above	O
were	O
washed	O
with	O
PBSE	O
containing	O
10	O
%	O
FBS	O
,	O
then	O
resuspended	O
and	O
smeared	O
on	O
a	O
microscope	O
slide	O
.	O

Slides	O
were	O
rapidly	O
air	O
dried	O
,	O
and	O
cells	O
were	O
fixed	O
for	O
5	O
min	O
in	O
methanol	O
(−	O
20	O
°	O
C	O
).	O

Following	O
methanol	O
fixation	O
,	O
slides	O
were	O
air	O
dried	O
and	O
mounted	O
with	O
4	O
',	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
phenylindole	O
(	O
DAPI	O
)	O
containing	O
antifade	O
reagent	O
ProlongGold	O
(	O
Invitrogen	O
,	O
http	O
://	O
www	O
.	O
invitrogen	O
.	O
com	O
/)	O
and	O
imaged	O
as	O
above	O
.	O

Lysosomal	O
morphology	O
studies	O
.	O

Trypanosomes	B-OG
were	O
resuspended	O
at	O
a	O
concentration	O
of	O
1	O
×	O
107	O
/	O
ml	O
in	O
F12	O
-	O
FBS	O
and	O
were	O
incubated	O
with	O
300	O
μg	O
/	O
ml	O
500	O
-	O
kDa	O
fluorescein	O
-	O
labeled	O
dextrans	O
(	O
Invitrogen	O
)	O
for	O
30	O
min	O
at	O
37	O
°	O
C	O
.	O

Cells	O
were	O
then	O
washed	O
three	O
times	O
with	O
1X	O
PBSE	O
and	O
were	O
incubated	O
at	O
3	O
×	O
106	O
/	O
ml	O
in	O
F12	O
-	O
FBS	O
with	O
either	O
2	O
units	O
of	O
normal	O
human	B-OG
serum	O
(	O
1	O
.	O
7	O
%	O
total	O
human	B-OG
serum	O
)	O
or	O
2	O
units	O
of	O
purified	O
TLF	O
(	O
0	O
.	O
017	O
%	O
TLF	O
),	O
and	O
cells	O
were	O
examined	O
after	O
30	O
min	O
or	O
2	O
h	O
.	O

Aliquots	O
were	O
treated	O
with	O
0	O
.	O
001	O
%	O
formaldehyde	O
on	O
ice	O
for	O
5	O
min	O
,	O
rinsed	O
with	O
PBS	O
,	O
and	O
resuspended	O
in	O
PBS	O
-	O
10	O
%	O
FBS	O
.	O

Cells	O
were	O
then	O
smeared	O
onto	O
a	O
slide	O
and	O
air	O
dried	O
.	O

For	O
co	O
-	O
localization	O
with	O
anti	O
-	O
p67	B-GP
,	O
cells	O
were	O
rehydrated	O
in	O
PBS	O
-	O
10	O
%	O
FBS	O
and	O
incubated	O
in	O
1	O
:	O
1000	O
anti	O
-	O
p67	B-GP
(	O
a	O
gift	O
of	O
Jay	O
Bangs	O
,	O
University	O
of	O
Wisconsin	O
,	O
Madison	O
,	O
Wisconsin	O
,	O
United	O
States	O
)	O
for	O
1	O
h	O
at	O
room	O
temperature	O
,	O
followed	O
by	O
staining	O
with	O
a	O
goat	B-OG
anti	O
-	O
mouse	B-OG
secondary	O
antibody	O
labeled	O
with	O
Alexa	O
Fluor	O
594	O
(	O
Invitrogen	O
).	O

Slides	O
were	O
rinsed	O
in	O
PBS	O
containing	O
1	O
%	O
glucose	O
,	O
air	O
dried	O
,	O
and	O
viewed	O
using	O
a	O
motorized	O
Zeiss	O
Axioplan2	O
and	O
an	O
MRm	O
camera	O
interfaced	O
with	O
the	O
Axiovisions	O
4	O
.	O
4	O
software	O
(	O
Zeiss	O
).	O

Hb	B-GP
binding	O
.	O

SPR	O
analysis	O
was	O
conducted	O
essentially	O
as	O
described	O
in	O
[	O
31	O
]	O
except	O
that	O
native	O
TLF	O
and	O
Hpr	B-GP
were	O
used	O
in	O
the	O
binding	O
assays	O
instead	O
of	O
recombinant	O
Hpr	B-GP
.	O

Hpr	B-GP
and	O
TLF	O
were	O
purified	O
from	O
fresh	O
human	B-OG
plasma	O
using	O
the	O
two	O
-	O
step	O
purification	O
method	O
[	O
14	O
].	O

In	O
the	O
case	O
of	O
Hpr	B-GP
purification	O
,	O
human	B-OG
HDLs	O
were	O
solubilized	O
using	O
10mM	O
CHAPS	O
and	O
purified	O
using	O
an	O
anti	O
-	O
Hpr	B-GP
column	O
as	O
described	O
[	O
14	O
].	O

The	O
Kd	O
for	O
the	O
Hpr	B-GP
–	O
Hb	B-GP
interaction	O
was	O
estimated	O
by	O
the	O
BIAevaluation	O
4	O
.	O
1	O
software	O
(	O
http	O
://	O
www	O
.	O
biacore	O
.	O
com	O
/	O
lifesciences	O
/	O
index	O
.	O
html	O
)	O
using	O
a	O
Langmuir	O
1	O
:	O
1	O
binding	O
model	O
.	O

For	O
precipitation	O
experiments	O
,	O
purified	O
TLF	O
was	O
incubated	O
with	O
Hb	B-GP
-	O
coupled	O
Sepharose	O
,	O
BSA	O
-	O
coupled	O
Sepharose	O
,	O
or	O
underivatized	O
Sepharose	O
.	O

After	O
extensive	O
washing	O
in	O
a	O
solution	O
containing	O
2	O
mM	O
CaCl2	O
,	O
1	O
mM	O
MgCl2	O
,	O
10	O
mM	O
Hepes	O
,	O
and	O
140	O
mM	O
NaCl	O
(	O
pH	O
7	O
.	O
8	O
),	O
bound	O
proteins	O
were	O
eluted	O
in	O
SDS	O
-	O
containing	O
sample	O
buffer	O
and	O
visualized	O
by	O
SDS	O
-	O
PAGE	O
.	O

TLF	O
binding	O
and	O
localization	O
.	O

Binding	O
studies	O
of	O
TLF	O
to	O
trypanosomes	B-OG
was	O
conducted	O
with	O
Alexa	O
Fluor	O
488	O
(	O
Invitrogen	O
)	O
labeled	O
TLF	O
,	O
and	O
Hb	B-GP
and	O
Hp	B-GP
noted	O
above	O
.	O

Trypanosomes	B-OG
were	O
incubated	O
with	O
labeled	O
TLF	O
,	O
unlabeled	O
Hb	B-GP
,	O
and	O
Hp	B-GP
at	O
4	O
°	O
C	O
for	O
1	O
h	O
.	O

The	O
cells	O
were	O
then	O
washed	O
three	O
times	O
at	O
1	O
,	O
400g	O
for	O
7	O
min	O
at	O
4	O
°	O
C	O
.	O

The	O
cells	O
were	O
resuspended	O
in	O
2	O
%	O
formaldehyde	O
at	O
4	O
°	O
C	O
until	O
measured	O
by	O
flow	O
cytometry	O
using	O
the	O
CyAn	O
ADP	O
(	O
Dako	O
,	O
http	O
://	O
www	O
.	O
dako	O
.	O
com	O
/)	O
and	O
analyzed	O
using	O
FlowJo	O
software	O
(	O
TreeStar	O
,	O
http	O
://	O
www	O
.	O
treestar	O
.	O
com	O
/).	O

Immunofluoresence	O
microscopy	O
was	O
employed	O
to	O
localize	O
TLF	O
and	O
Hb	B-GP
in	O
the	O
cell	O
.	O

Alexa	O
Fluor	O
488	O
(	O
Invitrogen	O
)–	O
labeled	O
TLF	O
and	O
Alexa	O
Fluor	O
594	O
(	O
Invitrogen	O
)–	O
labeled	O
Hb	B-GP
were	O
incubated	O
with	O
trypanosomes	B-OG
pre	O
-	O
incubated	O
with	O
50	O
μM	O
chloroquine	O
for	O
30	O
min	O
.	O

TLF	O
and	O
Hb	B-GP
were	O
added	O
at	O
the	O
concentrations	O
noted	O
in	O
Figure	O
7	O
.	O

LysoTracker	O
Red	O
DND99	O
(	O
Invitrogen	O
)	O
was	O
used	O
to	O
identify	O
the	O
lysosome	O
.	O

These	O
studies	O
were	O
done	O
on	O
a	O
Zeiss	O
Axioplan	O
and	O
the	O
images	O
analyzed	O
using	O
IPLab	O
Spectrum	O
version	O
3	O
.	O
9	O
.	O
4r2	O
from	O
Scanalytics	O
–	O
BD	O
Biosciences	O
(	O
http	O
://	O
www	O
.	O
scanalytics	O
.	O
com	O
/)	O

Supporting	O
Information	O

Hb	B-GP
Is	O
Necessary	O
for	O
Maximal	O
TLF	O
Killing	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG

Trypanosome	B-OG
killing	O
by	O
TLF	O
in	O
the	O
presence	O
(	O
open	O
circles	O
)	O
and	O
absence	O
(	O
closed	O
circles	O
)	O
of	O
Hb	B-GP
.	O

Hb	B-GP
alone	O
is	O
not	O
toxic	O
to	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
at	O
the	O
concentrations	O
tested	O
(	O
open	O
squares	O
).	O

TLF	O
used	O
in	O
these	O
studies	O
was	O
purified	O
by	O
the	O
two	O
-	O
step	O
procedure	O
.	O

(	O
25	O
KB	O
PPT	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Neither	O
Hb	B-GP
nor	O
TLF	O
Alone	O
Are	O
Efficiently	O
Taken	O
Up	O
by	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG

(	O
A	O
)	O
Alexa	O
Fluor	O
594	O
–	O
labeled	O
Hb	B-GP
or	O
Alexa	O
Fluor	O
488	O
–	O
labeled	O
TLF	O
was	O
incubated	O
with	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
brucei	I-OG
for	O
1	O
h	O
at	O
37	O
°	O
C	O
.	O

No	O
uptake	O
of	O
was	O
seen	O
at	O
either	O
488	O
nm	O
or	O
594	O
nm	O
excitation	O
.	O

(	O
B	O
)	O
When	O
cells	O
were	O
co	O
-	O
incubated	O
with	O
TLF	O
and	O
Hb	B-GP
,	O
both	O
TLF	O
and	O
Hb	B-GP
can	O
be	O
seen	O
in	O
the	O
trypanosome	B-OG
lysosome	O
by	O
co	O
-	O
localization	O
with	O
LysoTracker	O
.	O

TLF	O
used	O
in	O
these	O
studies	O
was	O
purified	O
by	O
the	O
two	O
-	O
step	O
procedure	O
.	O

(	O
283	O
KB	O
PPT	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Author	O
contributions	O
.	O
JW	O
,	O
MJN	O
,	O
AS	O
,	O
SKM	O
,	O
and	O
SH	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

JW	O
,	O
MJN	O
,	O
and	O
AS	O
performed	O
the	O
experiments	O
and	O
analyzed	O
the	O
data	O
.	O

JW	O
and	O
MJN	O
contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
.	O

JW	O
,	O
AS	O
,	O
SKM	O
,	O
and	O
SH	O
wrote	O
the	O
paper	O
.	O

Competing	O
interests	O
.	O
The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

